US20150075541A1 - Airway implants and methods and devices for insertion and retrieval - Google Patents

Airway implants and methods and devices for insertion and retrieval Download PDF

Info

Publication number
US20150075541A1
US20150075541A1 US14/312,218 US201414312218A US2015075541A1 US 20150075541 A1 US20150075541 A1 US 20150075541A1 US 201414312218 A US201414312218 A US 201414312218A US 2015075541 A1 US2015075541 A1 US 2015075541A1
Authority
US
United States
Prior art keywords
tissue
tongue
implant
patient
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/312,218
Inventor
Michael Dineen
Mark Hirotsuka
Jasper Jackson
Damien Shulock
Andrew Frazier
Chad Roue
Erik van der Burg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Koninklijke Philips NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/349,044 external-priority patent/US20060207606A1/en
Application filed by Koninklijke Philips NV filed Critical Koninklijke Philips NV
Publication of US20150075541A1 publication Critical patent/US20150075541A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/56Devices for preventing snoring
    • A61F5/566Intra-oral devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06166Sutures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/24Surgical instruments, devices or methods, e.g. tourniquets for use in the oral cavity, larynx, bronchial passages or nose; Tongue scrapers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0487Suture clamps, clips or locks, e.g. for replacing suture knots; Instruments for applying or removing suture clamps, clips or locks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00004(bio)absorbable, (bio)resorbable, resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00814Surgery of the tongue, e.g. glossoplasty
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00862Material properties elastic or resilient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00982General structural features
    • A61B2017/00986Malecots, e.g. slotted tubes, of which the distal end is pulled to deflect side struts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0403Dowels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0409Instruments for applying suture anchors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0412Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from suture anchor body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0414Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having a suture-receiving opening, e.g. lateral opening
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0417T-fasteners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/042Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors plastically deformed during insertion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/042Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors plastically deformed during insertion
    • A61B2017/0422Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors plastically deformed during insertion by insertion of a separate member into the body of the anchor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0427Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0427Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body
    • A61B2017/0429Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body the barbs being expanded by a mechanical mechanism which also locks them in the expanded state
    • A61B2017/043Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body the barbs being expanded by a mechanical mechanism which also locks them in the expanded state by insertion of a separate spreading member into the anchor
    • A61B2017/0433Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body the barbs being expanded by a mechanical mechanism which also locks them in the expanded state by insertion of a separate spreading member into the anchor the anchor or the separate member comprising threads, e.g. a set screw or a worm gear for moving spreading members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0427Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body
    • A61B2017/0435Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body the barbs being separate elements mechanically linked to the anchor, e.g. by pivots
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0427Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body
    • A61B2017/0437Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body the barbs being resilient or spring-like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0438Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors slotted, i.e. having a longitudinal slot for enhancing their elasticity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/044Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors with a threaded shaft, e.g. screws
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0446Means for attaching and blocking the suture in the suture anchor
    • A61B2017/0448Additional elements on or within the anchor
    • A61B2017/0451Cams or wedges holding the suture by friction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0446Means for attaching and blocking the suture in the suture anchor
    • A61B2017/0454Means for attaching and blocking the suture in the suture anchor the anchor being crimped or clamped on the suture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0446Means for attaching and blocking the suture in the suture anchor
    • A61B2017/0458Longitudinal through hole, e.g. suture blocked by a distal suture knot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0446Means for attaching and blocking the suture in the suture anchor
    • A61B2017/0461Means for attaching and blocking the suture in the suture anchor with features cooperating with special features on the suture, e.g. protrusions on the suture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0446Means for attaching and blocking the suture in the suture anchor
    • A61B2017/0461Means for attaching and blocking the suture in the suture anchor with features cooperating with special features on the suture, e.g. protrusions on the suture
    • A61B2017/0462One way system, i.e. also tensioning the suture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0464Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors for soft tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B2017/0496Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials for tensioning sutures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06166Sutures
    • A61B2017/06171Sutures helically or spirally coiled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06166Sutures
    • A61B2017/06176Sutures with protrusions, e.g. barbs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06166Sutures
    • A61B2017/0618Sutures elastic, e.g. stretchable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/24Surgical instruments, devices or methods, e.g. tourniquets for use in the oral cavity, larynx, bronchial passages or nose; Tongue scrapers
    • A61B2017/248Operations for treatment of snoring, e.g. uvulopalatoplasty
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/56Devices for preventing snoring

Definitions

  • Certain embodiments of the present invention are related to methods and devices for the treatment of airway obstruction, such as, for example, obstructive sleep apnea, and devices and methods that facilitate insertion and retrieval of the same.
  • This invention relates generally to a system and method for treating upper airway obstruction, sleep disordered breathing, upper airway resistance syndrome and snoring by manipulating the structures of the oropharynx, including the tongue.
  • Respiratory disorders during sleep are recognized as a common disorder with significant clinical consequences.
  • the human body exhibits different patterns of brain and muscle activity.
  • the REM sleep stage is associated with reduced or irregular ventilatory responses to chemical and mechanical stimuli and a significant degree of muscle inhibition.
  • This muscle inhibition may lead to relaxation of certain muscle groups, including but not limited to muscles that maintain the patency of the upper airways, and create a risk of airway obstruction during sleep.
  • muscle relaxation narrows the lumen of the airway, greater inspiratory effort may be required to overcome airway resistance. This increased inspiratory effort paradoxically increases the degree of airway resistance and obstruction through a Bernoulli effect on the flaccid pharyngeal walls during REM sleep.
  • OSA Obstructive Sleep Apnea
  • OSA is a sleep disorder that affects up to 2 to 4% of the population in the United States.
  • OSA is characterized by an intermittent cessation of airflow in the presence of continued inspiratory effort. When these obstructive episodes occur, an affected person will transiently arouse, regain muscle tone and reopen the airway. Because these arousal episodes typically occur 10 to 60 times per night, sleep fragmentation occurs which produces excessive daytime sleepiness. Some patients with OSA experience over 100 transient arousal episodes per hour.
  • OSA may also lead to cardiovascular and pulmonary disease. Apnea episodes of 60 seconds or more have been shown to decrease the partial pressure of oxygen in the lung alveoli by as much as 35 to 50 mm Hg. Some studies suggest that increased catecholamine release in the body due to the low oxygen saturation causes increases in systemic arterial blood pressure, which in turn causes left ventricular hypertrophy and eventually left heart failure. OSA is also associated with pulmonary hypertension, which can result in right heart failure.
  • Radiographic studies have shown that the site of obstruction in OSA is isolated generally to the supralaryngeal airway, but the particular site of obstruction varies with each person and multiple sites may be involved.
  • a small percentage of patients with OSA have obstructions in the nasopharynx caused by deviated septums or enlarged turbinates. These obstructions may be treated with septoplasty or turbinate reduction procedures, respectively. More commonly, the oropharynx and the hypopharynx are implicated as sites of obstruction in OSA.
  • A-P anterior-posterior direction
  • OSA is generally diagnosed by performing overnight polysomnography in a sleep laboratory.
  • Polysomnography typically includes electroencephalography to measure the stages of sleep, an electro-oculogram to measure rapid eye movements, monitoring of respiratory effort through intercostal electromyography or piezoelectric belts, electrocardiograms to monitor for arrhythmias, measurement of nasal and/or oral airflow and pulse oximetry to measure oxygen saturation of the blood.
  • weight loss programs are prescribed as part of their treatment plan, because of the association between obesity and OSA. Weight loss may reduce the frequency of apnea in some patients, but weight loss and other behavioral changes are difficult to achieve and maintain. Therefore, other modalities have also been used in the treatment of OSA, including pharmaceuticals, non-invasive devices and surgery.
  • Progesterone theophylline and acetozolamide have been used as respiratory stimulants, but each drug is associated with significant side effects and their efficacy in OSA is not well studied.
  • Protriptyline a tricyclic antidepressant that reduces the amount of REM sleep, has been shown to decrease the frequency of apnea episodes in severe OSA, but is associated with anti-cholinergic side effects such as impotence, dry mouth, urinary retention and constipation.
  • CPAP Continuous Positive Airway Pressure
  • OSA Continuous Positive Airway Pressure
  • These devices use a sealed mask which produce airflow at pressures of 5 to 15 cm of water and act to maintain positive air pressure within the pharyngeal airway and thereby maintain airway patency.
  • CPAP is effective in treating OSA, patient compliance with these devices is low for several reasons. Sleeping with a sealed nasal mask is uncomfortable for patients. Smaller sealed nasal masks may be more comfortable to patients but are ineffective in patients who sleep with their mouths open, as the air pressure will enter the nasopharynx and then exit the oropharynx.
  • CPAP also causes dry nasal passages and congestion.
  • Surgical treatments for OSA avoid issues with patient compliance and are useful for patients who fail conservative treatment.
  • One surgery used for OSA is uvulopalatopharyngoplasty (UPPP).
  • UPPP uvulopalatopharyngoplasty
  • This surgery involves removal of the uvula and a portion of the soft palate, along with the tonsils and portions of the tonsillar pillars.
  • snoring is reduced in a majority of patients who undergo UPPP, the percentage of patients who experience reduced frequency of apnea episodes or improved oxygen saturation is substantially lower.
  • Postoperatively, many patients that have undergone UPPP continue to exhibit oropharyngeal obstruction or concomitant hypopharyngeal obstruction.
  • Nonresponders often have physical findings of a large base of tongue, an omega-shaped epiglottis and redundant aryepiglottic folds.
  • UPPP is not a treatment directed at these structures.
  • UPPP also exposes patients to the risks of general anesthesia and postoperative swelling of the airway that will require a tracheostomy. Excessive tissue removal may also cause velo-pharyngeal insufficiency where food and liquids enter into the nasopharynx during swallowing.
  • LAUP Laser-assisted uvulopalatopharyngoplasty
  • GHM hyoid myotomy
  • an antero-inferior portion of the mandible which includes the attachment point of the tongue musculature, is repositioned forward and in theory will pull the tongue forward and increase airway diameter.
  • the muscles attached to the inferior hyoid bone are severed to allow the hyoid bone to move superiorly and anteriorly.
  • Repositioning of the hyoid bone expands the retrolingual airspace by advancing the epiglottis and tongue base anteriorly.
  • the hyoid bone is held in its new position by attaching to the mandible using fascia. Variants of this procedure attach the hyoid bone inferiorly to the thyroid cartilage.
  • LMG laser midline glossectomy
  • a receding mandible, mandibular or maxillomandibular advancement surgeries may be indicated for treatment of OSA.
  • These patients are predisposed to OSA because the posterior mandible position produces posterior tongue displacement that causes airway obstruction.
  • a mandibular advancement procedure the mandible is cut bilaterally posterior to the last molar and advanced forward approximately 10 to 14 mm. Bone grafts are used to bridge the bone gap and the newly positioned mandible is wire fixated to the maxilla until healing occurs.
  • Mandibular advancement may be combined with a Le Fort I maxillary osteotomy procedure to correct associated dental or facial abnormalities. These procedures have a high morbidity and are indicated only in refractory cases of OSA.
  • a tissue-tensioner is used to tension a region of tissue.
  • the tissue tensioner is used to engage certain tissue of the body and apply tension to those tissues.
  • a tissue engaging structure can be positioned on the tongue, and the device is manipulated to displace at least a portion of the posterior tongue in an anterior or lateral direction, or to alter the tissue tension or compliance of the tongue.
  • a tissue tensioner for treating a condition of a patient's airway, said tissue tensioner including an elongate flexible tether having a first end and a second end; a bone anchor configured to be connected to a patient's mandible; and a tissue ingrowth implant configured to be implanted in a patient's tongue.
  • the tissue ingrowth implant can be connected to the second end of the tether.
  • the tissue tensioner can also include an adjustment mechanism configured to be held by the bone anchor adjacent the patient's mandible.
  • the adjustment mechanism can be configured to receive the first end of the tether, as well as configured to adjust tension in the flexible tether between the patient's mandible and the patient's tongue.
  • the elongate member can include either an active variable length tether or a coating tending to cause tissue ingrowth.
  • the adjustment mechanism can include a rotational assembly such as a spool.
  • a tissue tensioner for treating a condition of a patient's airway, the tensioner including an elongate flexible tension member; a first portion of the tension member configured to be secured relative to a body tissue; and a second portion of the tension member including a tissue ingrowth material configured to be secured to a portion of a tongue; and an adjustment mechanism configured to adjust tension in the tension member between the body tissue and said portion of the tongue.
  • the first portion of the tension member can be connected to either a bone anchor or a tissue anchor.
  • the tissue ingrowth material is a single strand of woven material which may be partially covered by a cap element. The cap element can be radiopaque.
  • the tension member can be beaded in some embodiments.
  • a method for treating airway obstruction includes the steps of placing a tissue tensioner within a patient's tongue, the tensioner including a flexible elongate tension member having a first portion configured to be secured relative to a body tissue and a second portion that is connected to a tissue ingrowth material; an adjustment mechanism configured to adjust tension in the tension member between the body tissue and the tissue ingrowth material; securing the first portion relative to a body tissue and implanting the tissue ingrowth material within a portion of the tongue; and adjusting the tension of the tension member by manipulating the adjustment mechanism.
  • the first portion is either secured relative to a patient's mandible using a bone anchor, or secured to tongue tissue using a tissue anchor.
  • the tissue ingrowth implant includes a single strand of woven material.
  • a tissue tensioner for treating a condition of a patient's airway, including an elongate flexible tension member comprising a first portion and a second portion; the first portion of the tension member being securable relative to a body tissue; the second portion being connected to a tissue ingrowth material; and means for adjusting the tension between the tissue ingrowth material and the body tissue.
  • the first portion of the tension member can be configured to be connected to either a bone anchor or a tissue anchor.
  • a tissue tensioner for treating a condition of a patient's airway that includes a flexible elongate tension member having a first portion and a second portion.
  • the first portion can be securable relative to a body tissue, and the second portion can be connected to an implant including a single woven strand and configured to be implanted in a patient's tongue.
  • a cap element can cover a portion of the woven implant.
  • a method for treating airway obstruction including the steps of deploying a tissue tensioner into a patient's tongue, the tissue tensioner including a flexible elongate tension member having a first portion secured relative to a body tissue and a second portion including a single strand woven implant that can be implanted in a patient's tongue.
  • the method also includes the step of removing the tissue tensioner from the patient by pulling on the single strand with sufficient force such that the woven implant unravels.
  • the first portion may be secured either relative to the patient's mandible or within the patient's tongue.
  • the locking bar can be configured to prevent migration of the first portion relative to the second portion.
  • a method for treating a condition of a patient's airway including the step of positioning a tissue tensioner within a patient.
  • the tissue tensioner can include a flexible, elongate elastic member having a first portion secured relative to a body tissue and a second portion comprising a tissue ingrowth material implanted in a portion of the tongue.
  • a locking bar is preferably releasably attached to the first portion and the second portion to prevent migration of the first portion with respect to the second portion. The locking bar can be manually pulled out to allow migration of the first portion with respect to the second portion.
  • a method for removing a tissue tensioner including the steps of providing a tissue tensioner, the tissue tensioner comprising a batten implant connected to a flexible tether; threading the flexible tether through a dilator; advancing the dilator over the flexible tether through tissue to the batten implant; advancing a cannula over dilator and over the implant; and removing the batten implant, the cannula, and the dilator.
  • at least a portion of the tissue ingrowth material is covered by a cap element.
  • a method for treating a condition of a patient's airway including the steps of passing a first tension member through a patient's genioglossus muscle exiting the dorsum lateral to a midline of the patient's tongue creating a first exit hole; passing a second tension member through the patient's genioglossus muscle exiting the dorsum lateral to the midline of the patient's tongue creating a second exit hole; passing a sling element under the tongue surface though the first exit hole and the second exit hole; attaching the first tension member to a first portion of the sling; attaching the second tension member to a second portion of the sling; and securing first and second tension members relative to body tissue.
  • the first and second tension members are secured to bone anchors.
  • a method for treating airway obstruction including the steps of placing a tissue tensioner within a patient's oral cavity, the tensioner including a flexible elongate tension member having a first portion configured to be secured relative to a body tissue and a second portion that is connected to a tissue ingrowth material; an adjustment mechanism configured to adjust tension in the tension member between the body tissue and the tissue ingrowth material; securing the first portion relative to a body tissue and implanting the tissue ingrowth material within a portion of the patient's soft palate; and adjusting the tension of the tension member by manipulating the adjustment mechanism.
  • the first portion is secured relative to a patient's hard palate.
  • a tissue tensioner for treating a condition of an airway, the tissue tensioner including: an elongate flexible tension member, a first portion of the tension member connected to a first tissue ingrowth material and a second portion of the tension member connected to a second tissue ingrowth material; and an adjustment mechanism configured to adjust tension in the tension member between the first tissue ingrowth material and the second tissue ingrowth material.
  • the first tissue ingrowth material is implanted in a first body tissue and the second tissue ingrowth material is implanted in a second body tissue.
  • a method for treating airway obstruction including placing a tissue tensioner within the tongue, the tensioner including a flexible elongate tension member having a first portion connected to a first tissue ingrowth material and a second portion connected to a second tissue ingrowth material; implanting the first tissue ingrowth material in a first portion of the tongue and implanting the second tissue ingrowth material in a second portion of the tongue; and adjusting the tension or length of the tension member by manipulating an adjustment mechanism configured to adjust tension in the tension member between the first tissue ingrowth material and the second tissue ingrowth material.
  • tissue tensioner for treating a condition of a patient's airway
  • the tissue tensioner including an elongate flexible tension member, a first portion of the tension member including a tissue anchor configured to be secured to a first portion of a patient's tongue and a second portion of the tension member including a tissue ingrowth material configured to be secured to a second portion of the patient's tongue.
  • the tissue anchor may include a fishbone anchor that has a plurality of barbs extending radially from the tension member.
  • a method for treating airway obstruction including placing a tissue implant within a patient's tongue or palate, the tissue implant comprising a multiple-pronged stiffening element; and expanding the stiffening element within the tongue or palate to stretch tissue laterally.
  • the stiffening implant may have at least one, two, three, four, five, or more prongs.
  • FIG. 1 illustrates tongue and soft palate implants including adjustment elements to adjust the tension of a tether, according to one embodiment of the invention.
  • FIG. 2 is a schematic diagram showing one example of a securement assembly that may be used with a tongue or hyoid suspension system, according to one embodiment of the invention.
  • FIG. 3 shows tongue and soft palate implants comprising tethers with a beaded shape, according to one embodiment of the invention.
  • FIGS. 4A-C depict a tongue suspension system comprising a multi-piece sling, according to one embodiment of the invention.
  • FIG. 5 shows a tongue suspension system with an elongated member comprising a double-ended anchor, according to one embodiment of the invention.
  • FIGS. 6A-B illustrate an anchor with a plurality of barbs that may be self-expandable, according to one embodiment of the invention.
  • FIGS. 7A-B show an implant comprising a multi-pronged stiffening element, according to one embodiment of the invention.
  • FIGS. 8A-B illustrate a woven tissue implant that can be conveniently removed after implantation, according to one embodiment of the invention.
  • FIGS. 9A-C show a tissue implant that comprises a locking rod, according to one embodiment of the invention.
  • FIGS. 10A-C illustrate a recapture/removal tool for a batten-style implant, according to one embodiment of the invention.
  • Causes of airway obstruction include but are not limited to obstructive sleep apnea, snoring and congenital disorders such as Pierre-Robin syndrome.
  • Disclosed herein are various embodiments of devices or implants and methods for treating causes of airway obstruction. Embodiments described herein relate to, for example, adjustability, tethers, and anchors of those implants to treat said conditions. Also disclosed herein are methods and devices for deployment and retrieval of the implants disclosed. Some of such devices and methods are further described in co-pending application Ser. No. 11/349,040, filed Feb. 7, 2006, as well as in U.S. Patent Publication Nos. 2005/0092332 and 2005/0092334 to Conrad et al.
  • Conrad discloses implants and methods of using the implants to alter the geometry and position of the tongue and soft palate.
  • Embodiments disclosed herein may also be adapted for use with the PILLAR® system of Restore Medical (St. Paul, Minn.).
  • FIG. 1 of Conrad illustrates an implant 10 that may be completely implanted within the tongue T, or alternatively, the soft palate SP.
  • the implant 10 comprises an elongated member 12 having a tissue in-growth end 14 and a static end 16.
  • the elongated member 12 a may be resilient, e.g., in the form of a spring member which may be stretched to create a bias urging tissue in-growth 14 a and static ends 16 a of the spring together.
  • the implant may comprise a bioresorbable material 20 positioned between the tissue-engaging end 14 a of the elongated member 12 a and an anchor 18 a .
  • the tissue in-growth end 14 a may be a tissue growth inducing material (e.g., felt or PET) to induce growth of tissue into the end to secure the end to surrounding tissue following implantation.
  • An anchor 18 a positioned proximally (e.g., a threaded eye-bolt) is secured to the mandible JB for tongue implants, and the hard palate HP for soft palate SP implants 10′.
  • the static end 16 of the elongated member 12 is secured to the anchor 18.
  • the tissue in-growth end 14 is placed in the tongue T near the tongue base TB.
  • a surgeon adjusts the tension of the suture 12, causing the tongue base TB to be advanced toward the mandible JB thereby placing the tissue of the tongue T in compression.
  • the surgeon may tie off the static end 16 at the anchor 18 retaining the tissue of the tongue T under tension.
  • Other anatomical structures shown include the trachea TR, epiglottis EP, esophagus ES, pharyngeal wall PW, trailing end of the soft palate TE, mouth M, and nasal cavity N.
  • tissue in-growth material 118 deployed proximally acts as an embedded anchor and eliminates the need for placement of an anchor in the mandible JB.
  • FIG. 1 of Conrad illustrates an implant 10 that includes an elongated member 12 (also referred herein as a tether or a tension member) having a tissue in-growth end 14 and a static end 16.
  • the elongated member may be resilient, e.g., in the form of a spring member 12 a which may be stretched to create a bias urging tissue in-growth 14 a and static ends 16 a of the spring 12 a together.
  • the implant 10 a may comprise a bioresorbable material 20 positioned between the tissue-engaging end 14 a of the elongated member 12 a and an anchor 18 a .
  • the tissue in-growth end 14 a may be a tissue growth inducing material (e.g., felt or PET) to induce growth of tissue into the end to secure the end to surrounding tissue following implantation.
  • the devices discussed above can also include one or more adjustment elements, for example, one or more adjustment elements selected from those described in the Frazier '519 publication (e.g., those illustrated in FIGS. 61A-K of the Frazier '519 publication), the '230 provisional application (e.g., those illustrated in FIGS. 73-108 of the '230 provisional application), or the Dineen '642 application (e.g., those illustrated in FIGS. 73-98 of the Dineen '642 application). Adjustment elements can advantageously allow for adjusting the tension of the elongated member disclosed in Conrad after implantation of the tongue or palatal suspension system.
  • a tongue or palatal remodeling system, device, and/or method for treating a patient with breathing problems that can be adjusted either before, during and/or after the initial implantation procedure may be better tolerated and less prone to treatment failure.
  • the tension or bias of the elongated member disclosed in Conrad by methods other than by cutting and re-tying the elongated member at times other than during implantation, migration, extrusion, and/or dysphagia may be avoided or corrected.
  • the improved tongue suspension system 5020 includes one or more spools or rotation assemblies 5020 , such as a spool assembly illustrated in FIGS. 61A to 61I of the Frazier '519 publication, for adjusting the tension of an elongated member 5012 between the mandibular anchor 5018 (attached to static end 5016 of the system) and the tissue in-growth end 5014 of the elongated member 5012 , such as one disclosed in Conrad.
  • a improved palatal suspension system 5030 is also shown in FIG.
  • the tongue suspension system including one or more spools or rotation assemblies 5020 ′ for adjusting the tension of an elongated member 5012 ′ between a bone or hard palate anchor 5018 ′ (attached to static end 5016 ′ of the system) and the tissue in-growth end 5014 of the elongated member 5102 ′ attached to the soft palate.
  • the elongated member may be configured to adjust the tension between a soft tissue anchor and the tissue ingrowth end.
  • the aforementioned implants may include one or more securement mechanisms selected from those disclosed in disclosed in the Frazier '519 publication, (e.g., securement mechanisms illustrated in FIGS. 40-51 of the Frazier '519 publication) which may be configured for use a system such as the one disclosed in Conrad.
  • the bone anchor disclosed in Conrad may be replaced by a securement mechanism as disclosed in the Frazier '519 publication.
  • the securement mechanism may be configured to hold the elongated member disclosed in Conrad or one or more tethers disclosed in, for example, the Frazier '519 publication or the Hirotsuka '752 application.
  • the tongue or soft palate implant such as one disclosed in Conrad includes a bone anchor 186 with a clamping interface 188 for retaining tethers 28 , as illustrated in connection with FIGS. 40A-C of the Frazier '519 publication.
  • the clamping interface 188 comprises two opposing surfaces 190 , 192 or structures that are adapted to provide a frictional or mechanical interface with tethers 28 or other elongate members inserted within the clamping interface 188 .
  • the clamping interface 188 has an open configuration depicted in FIGS.
  • the clamping interface 188 may further comprise complementary indentations 194 and protrusions 196 to further enhance the frictional resistance of the interface in the closed configuration.
  • the opposing surfaces or structures of the clamping interface may also be configured with frictional surfaces that are well known in the art through the use of various materials, surface treatments or configurations. Frictional surface configurations may also include cross hatched surfaces or irregular porous surfaces.
  • Conrad teaches an elongated member having a tissue in-growth end and a static end.
  • the elongated member 12 a may be resilient, e.g., in the form of a spring member 12 a which may be stretched to create a bias urging tissue in-growth 14 a and static 16 a ends of the spring together.
  • An elongated member, such as one disclosed in Conrad may include any one of various tethers disclosed in the Frazier '519 publication (e.g., those illustrated in FIGS. 27-38 of the Frazier '519 publication), the '285 provisional application (e.g., those illustrated in FIGS.
  • a tether with elastic properties or comprising structures that provide a length/tension relationship may be preferred in some instances.
  • a tether capable of lengthening in response to increased load or tension may be optimized to provide sufficient bias to reduce the effects of oropharyngeal occlusion while providing a more physiologic range of tongue or soft palate motion than that produced by fixed length tethers.
  • a tether with elastomeric properties may be provided by using materials such as but not limited to urethane or silicone.
  • materials such as but not limited to urethane or silicone.
  • One skilled in the art can select the particular material, tether length, diameter, cross-sectional shape and other features based upon the desired effect, tolerances, and the particular patient's anatomical characteristics.
  • Other materials that may comprise the tether include but are not limited to Nitinol, spring steel, tantalum, polyethylene, polyester, silk, polypropylene, polyolefin or a combination thereof.
  • tether configurations that may be used include passive and active variable length or bias structures such as braided or woven structures, electropolymers, springs, coils, magnets or solenoids.
  • the tether configuration may actively change in length or configuration resulting from the application of external energy or force such as electrical current or magnets.
  • These active tether configurations may be further configured with local or distal sensor components that may modulate the activity of the external energy or force acting on the active tether. The modulation may be influenced or triggered by detection of diaphragm movement or depolarization activity, nerve depolarization, pressure changes and/mechanical contact in the airway.
  • the tether may also be covered by a lubricious biocompatible coating.
  • the tether comprises a bioabsorbable coating that may cause scar or connective tissue formation about the tether. Scar tissue formation may further enhance the effect of the glossoplasty implant by tightening the tongue tissue (or similarly with regard to a palatal implant) and/or to resist migration of the implant.
  • a tether of a tissue engaging member may be configured with one or more structures or surfaces capable of engaging at least a portion of the tissue surrounding the tether so that an anchor is not required, or to distribute the tissue engagement.
  • the tissue engaging member may comprise multiple anchors and multiple tethers arranged in a serial or branching fashion.
  • FIG. 3 illustrates an embodiment of tongue 5050 and soft tissue 5050 ′ implants, both comprising a beaded tether 5040 , 5040 ′, as disclosed in, for example, the Frazier '519 publication, the '285 provisional application, and the Hirotsuka '752 application.
  • the beaded tether 5040 , 5040 ′ may advantageously promote tissue in-growth and better tension the tongue 5050 or soft palate 5050 ′ suspension system.
  • one or more tethers selected from the tethers disclosed in the Frazier '519 publication, the '285 provisional application, or the Hirotsuka '752 application replace the elongated member disclosed in Conrad.
  • an improved tongue suspension system 5060 comprises a tether further comprising one or more “sling” elements 5062 on a tongue or palate-based implant system such as disclosed in Conrad.
  • the sling element 5062 may comprise, for example, a batten of porous fabric, woven material, a large diameter suture, braid, band, and the like.
  • the sling element 5062 may be operably connected to, or replace the elongated member disclosed in Conrad.
  • the sling element 5062 comprises a central lumen configured to receive one or more sutures within the lumen.
  • the sling element 5062 may alleviate trauma during installation of the tongue suspension system 5060 because the enlarged suture portion 5062 need not be passed through the entire tongue T.
  • the sling 5062 can also advantageously increase anchoring surface area in the tongue T and prevent undesired migration of the elongated member.
  • a method of deploying an improved tongue suspension system 5060 comprising a sling element 5062 is disclosed herein, and illustrated in FIGS. 4A-4C .
  • the method comprises the step of passing a first elongated member 5064 through the genioglossus muscle 5100 exiting the dorsum lateral to the midline.
  • a second elongated member 5066 is passed through the genioglossus muscle 5100 exiting the dorsum lateral to the midline on the contralateral side.
  • a sling element 5062 is passed under the tongue T surface between exit holes created from the passing of the first 5064 and second 5066 elongated members through the genioglossus muscle 5100 .
  • elongated members 5064 , 5066 such as sutures are attached to each end of the sling element 5062 .
  • the portion of the elongated member within the sling element may be secured within the lumen of the sling element 5062 .
  • the elongated members 5064 , 5066 outside of the sling element may then be attached to the bone anchor 5068 .
  • the sling element 5062 is formed during the procedure by passing a plurality of sutures transversely through the tongue along different pathways. The ends of the sutures located to each side of the midline tongue are then joined together to form the ends of the sling element.
  • the in situ formed sling element can then be attached to the first and second sutures as described above.
  • Conrad teaches an elongated member having a tissue in-growth end.
  • the elongated member 12 has two tissue in-growth ends (e.g., felt or PET); a proximal in-growth end 118 acting as an embedded anchor eliminating the need for placing an anchor in the mandible, and a distal in-growth end 14 for tensioning the tongue suspension system.
  • a tongue suspension system comprises an implant with one or more anchors selected from the anchors disclosed in the Frazier '519 publication (e.g., as illustrated in FIGS.
  • the tissue in-growth ends may comprise double-ended anchors 5080 as illustrated, for example, in FIGS. 86-112 of the '058 provisional application, or the anchors of the Jackson '652 application.
  • the anchor may be operably connected to the elongated member as disclosed in Conrad, or a tether as disclosed in the Frazier '519 application, '058 provisional application, or the Jackson '652 application as noted above.
  • Other tissue ingrowth materials that may be used include polypropylene, polytetrafluoroethylenes, polyurethanes, polyesters, ceramics, porous metals or combinations thereof.
  • bioglues may be used to facilitate tissue adhesion to the implant. Bioglues may be injected at the implantation site or provided as a coating on the implant. A bioglue coating may provided at the point of manufacture or the point of service.
  • a tongue suspension system may include a first tissue ingrowth portion and a second tissue ingrowth portion, connected by a flexible elongate tether.
  • the length and/or tension of the tether can be adjusted using an adjustment mechanism described herein, for example, a spool.
  • soft palate implants such as those disclosed in Conrad may include one or more anchors 5082 ′ selected from those disclosed in the Frazier '519 publication (e.g., FIGS. 63-69 of the Frazier '519 publication) replacing the one or more tissue ingrowth ends of the expandable member, for example, as illustrated in Conrad FIGS. 1-2.
  • an improved tongue or palatal suspension system comprises one or more tissue-engaging anchors 5090 as illustrated schematically in FIGS. 6A-B herein.
  • the anchor 5090 may be deployed distally, proximally, or both distally and proximally (relative to the position of the tongue or the palate), and connected by a tether that is preferably elongate and flexible in some embodiments.
  • the anchor 5090 may optionally comprise a plurality of “fish bone” shaped barbs 5092 in series extending radially out from and operably connected at one end to the anchor 5090 as illustrated.
  • the angles of the barbs 5092 when fully deployed may range anywhere from about 0 degrees to about 180 degrees with respect to vector of insertion, preferably about 45 degrees to 135 degrees, and most preferably about 60 degrees to about 150 degrees.
  • the angles of the barbs 5092 may be uniform or non-uniform along the length of the implant 5090 .
  • the barbs 5092 in FIGS. 6A-B are arranged in pairs within a common plane of orientation, in other embodiments the barbs 5092 may be unpaired and/or circumferentially arranged.
  • the barbs 5092 may be made of Nitinol, other metals, one or more polymers, or other suitable material. In some embodiments, the barbs 5092 may be bioabsorbable to decrease tissue irritation as well as to facilitate tissue ingrowth.
  • the anchor 5090 may be predeployed in a first, collapsed configuration, as schematically illustrated in FIG. 6A within a delivery tube (not shown). Upon removal of the delivery tube, for example, within the genioglossus muscle, the barbs 5092 spring outward to engage the tissue, as shown in FIG. 6B .
  • the anchor 5090 may be attached to an adjustable securement assembly as described above and disclosed in the Frazier '519 publication. The adjustability is especially advantageous when the anchor 5090 is placed untensioned, and tensioned at a later time after a healing and tissue ingrowth period.
  • the anchor 5090 disclosed herein may also be configured for use for soft palate implants as disclosed in Conrad, as well as Conrad '307.
  • FIG. 8 of Conrad illustrates contracting implants 40 that may be placed in the tongue T in-line with radiating lines A of certain muscles of the tongue (e.g., genioglossus muscles). As the implants 40 contract over time, they urge the tongue T from collapsing toward the pharyngeal wall PW.
  • FIG. 12-13 of Conrad illustrates implants 120 spaced apart for fibrosis to interconnect between the implants 120.
  • FIGS. 14-17 of Conrad illustrate the use of embedded crimps or staples 150 to stiffen and potentially illustrate the tongue base. In the embodiments shown in FIGS. 14-15, the crimps 150 are slightly curved members which are placed in the tongue with concave surfaces opposing the tongue base. The crimping acts to squeeze tissue of the tongue to stiffen the tongue.
  • a multi-pronged stiffening element 5100 schematically illustrated implanted in a soft palate herein in FIGS. 7A-B .
  • the stiffening element 5100 may have at least about two, three, four, five or more prongs and be implanted, for example, in the tongue, palate, and the like.
  • the stiffening element 5100 increases stiffness within the implanted tissue by stretching the tissue in one or more directions. In some embodiments, the tissue is stretched laterally.
  • the stiffening element 5100 is trident-shaped as shown. However, one of ordinary skill in the art will appreciate that many other possible shapes are possible.
  • the stiffening element may be expandable after delivery.
  • FIGS. 8A-B illustrate an embodiment of an improved woven tissue implant 5104 that can advantageously be easily removed, from, e.g., the tongue or the soft palate.
  • the implant 5104 may be a batten type stiffener or tissue anchor formed from a single strand.
  • the single strand can be woven or knitted into a desired shape, for example, a rod-like structure.
  • the woven tissue implant 5104 may be deployed into tissue to stiffen a particular area and serve a similar function to the implants illustrated in FIGS. 8 and 12-17 of Conrad or implants of the PILLAR® system (Restore Medical), or attached to one or more tethers for use as a tissue anchor or sling.
  • the woven design facilitates tissue ingrowth within the spaces around the woven implant 5014 , effectively increasing the surface area of the implant 5104 and increasing the implant's anchoring force.
  • the implant 5104 is most preferably configured to have sufficient structural integrity necessary to anchor tissue. However, the woven implant 5104 is also preferably configured such that pulling on an end of the single strand of the implant with an appropriate force will unwind or unravel the implant 5104 into a long filament (as shown in FIG. 8B ) for simple and convenient removal of the implant.
  • the appropriate force required to unwind the implant 5104 is most preferably sufficiently greater than the tensioning force of the tissue on the implant 5104 while deployed in the tongue, palate, or surrounding tissue so that the implant 5104 does not undesirably unwind while deployed.
  • Part or all of the implant 5104 may include a radiopaque marker material.
  • the implant may comprise a bioresorbable material 20 positioned between the tissue-engaging end 14 a of the elongated member 12 a and an anchor 16 a .
  • the bioresorbable material 20 may oppose a spring member 12 a which may be stretched to create a bias urging ends 14 a , 16 a of the elongated member 12 a toward one another.
  • the bioresorbable material 20 positioned between the tissue-engaging end 14 a and a bolt 18 a will later resorb into the tissue of the tongue T permitting the end to be urged toward the bolt 18 a by the resilience of the spring 12 a , tensioning the device.
  • FIG. 9 herein illustrates an improved embodiment of a tether 5108 that may be used with tissue ingrowth implants, such as, for example, those disclosed in Conrad.
  • An improved tether 5108 comprises a locking bar 5112 releasably attached to both the tissue ingrowth end 5014 and the bone anchor 5018 (or both tissue ingrowth ends in some embodiments) and disposed within an elastic member 5110 .
  • the elastic member 5110 is preferably connected to an implant or anchor 5014 (such as the tissue ingrowth engaging member of Conrad) at a first end and a securing element 5018 (such as a bone anchor) or another tissue anchor at a second end.
  • the locking bar 5112 may comprise one or more forked or capped ends 5113 .
  • the locking bar 5112 may comprise metal, polymer, or other biocompatible material, but preferably has a relatively low elasticity to prevent migration of the implant or anchor 5014 in the acute post-implantation period. During this period, there may be inadequate tissue ingrowth for the implant or anchor 5014 to provide a sufficient anchoring force to tension the tether 5110 .
  • Other tethers that can also be used to provide a temporary or permanent anchoring force are disclosed in, for example, the Frazier '519 publication, the '285 provisional application, and the Hirotsuka '752 application.
  • the locking bar 5112 provides the appropriate anchoring force until adequate tissue ingrowth occurs and the elastic member 5110 can be appropriately tensioned (as an alternative, for example, to the bioresorbable material solution illustrated in FIG. 3 of Conrad).
  • the locking bar 5112 may be removed via a recapture tool as disclosed elsewhere in the application and the Frazier '519 publication (e.g., at FIGS. 70-72 of the Frazier '519 publication).
  • the locking bar 5112 can be accessed via a surgical procedure and pulled out manually.
  • the locking bar 5112 may comprise a tether line running to the bone anchor 5018 which can be used with a percutaneous recapture system, such as the system disclosed in the Frazier '519 publication, for removal.
  • a dilator tool can follow the tether to an end of the locking bar 5112 , and the locking bar 5112 could then be pulled out.
  • the locking bar 5112 is made from a smooth material (e.g., a metal or plastic rod) the tether line can be pulled directly to remove the bar without the need for a dilator tool.
  • the locking bar 5112 may be made of a biodegradable material, such as polylactic acid, polyglycolic acid and the like, that degrades at a rate slow enough to continue to provide anchoring force to the implant 5014 until adequate tissue ingrowth allows the elastic member 5110 to be appropriately tensioned.
  • An improved batten-style implant 5120 illustrated in FIGS. 10A-C herein, comprises one or more cap elements 5122 .
  • the cap elements 5122 are preferably attached to the proximal end, distal end, or both ends of the batten implant. In some embodiments, the cap element 5122 covers a substantial portion, or even the entire batten implant 5120 .
  • the cap element 5122 may be made of, for example, plastic, metal, Dacron, ePTFE, and the like.
  • the cap element 5122 comprises radiopaque material such that the cap 5122 can be visualized on plain film radiographs.
  • the cap element 5122 comprises material that can be visualized on ultrasound, magnetic resonance imaging, or other imaging modalities.
  • the cap elements 5122 can advantageously assist in guiding an implant removal device, such as a cannula 5124 , onto the main body of the implant 5120 such that the cutting edges of the removal device 5124 can separate the fibrous encapsulation near the implant surface without cutting into, or otherwise damaging the implant body 5120 .
  • the cap elements 5122 may be especially advantageous when the implant 5120 is tethered, for example, when the implant 5120 is used as a tissue anchor to apply traction to the tongue or the palate.
  • the cap elements 5122 may allow the batten implant 5120 to readily and safely removed from tissue while minimizing tissue trauma and reducing the risk of damage to the implant 5120 complicating removal through increased force or cutting or tearing of the implant 5120 .
  • a method for recapturing a batten implant 5120 will be described.
  • trailing sutures 5012 are threaded through a dilator with a cannula assembly 5124 , such as a recapture tool depicted in FIGS. 7G to 7J and FIGS. 70-72 of the Frazier '519 publication.
  • the cannula and dilator 5124 are advanced over the sutures 5012 and through tissue to the batten implant 5120 .
  • the cannula and dilator 5124 may be guided by, for example, an appropriate technique to detect the imaging marker, such as fluoroscopy, ultrasound, CT, MRI, and the like. Fibrous tissue may be dissected from the sutures 5012 using the dilator 5124 . Then, in embodiments of implants 5120 that comprise one or more cap elements 5122 , the cannula 5124 is advanced over the implant 5120 when the dilator 5124 reaches the cap element 51 .
  • the cap element 5122 is preferably configured to be harder in texture than the surrounding peri-implant fibrous tissue, allowing the cannula 5124 to be guided over the implant body 5120 without cutting the softer material of the implant body.
  • the implant 5120 and recapture assembly 5124 is removed.
  • a delivery tool comprises a pushrod attached to an actuator handle, the pushrod having a distal position and a proximal position which can be manipulated by a user through the actuator handle.
  • An implant comprising a tissue ingrowth end, static end, and an elongated member, therebetween, such as, for example, an implant illustrated in FIGS.
  • 1-4 of Conrad may be loaded into the delivery tool by attaching the end(s) of the elongated member to an attachment site on a spool within the delivery tool.
  • the elongated member is attached to the spool and the dial attached to the spool is rotated, the elongated member, including the tissue ingrowth end, are pulled into the tubular body as the elongated member is wound around the spool.
  • the proximal pulling of the tissue ingrowth end into the delivery tube causes the tissue ingrowth end to retract into a relatively compact delivery profile configuration and into the tubular body.
  • the actuator handle overcomes the bias of the resistance structure to release the rotation resistance.
  • tissue ingrowth end This allows the spool to freely rotate and to quickly deploy the tissue ingrowth end, followed by the rest of the elongated member, into the tissue.
  • the speed with which the tissue ingrowth end is deployed may affect the degree of tissue engagement by the tissue ingrowth end. In some instances, it is desirable to reduce rotation resistance in the delivery phase compared to the loading phase of the delivery tool usage.
  • a tongue or soft palate implant may have one or more elements of different embodiments described herein, for example, one or more anchors disclosed in the Frazier '519 publication, '058 provisional application, or Jackson '652 application and one or more adjustment elements described in the Frazier '519 publication, '230 provisional application, or the Dineen '642 application.
  • the invention encompasses other combinations of any or all of the disclosures of the aforementioned references. For all of the embodiments described above, the steps of the methods need not be performed sequentially.

Abstract

Embodiments of the present invention relate to methods and devices for the treatment of airway obstruction, such as obstructive sleep apnea, and devices and methods that facilitate insertion and retrieval of the same. In one embodiment, disclosed is a tissue tensioner that includes an elongate flexible tether having a first end and a second end, a bone anchor configured to be connected to a patient's mandible, a tissue ingrowth implant configured to be implanted in a patient's tongue and connected to the second end of the tether, and an adjustment mechanism configured to be held by the bone anchor adjacent the patient's mandible and configured to receive the first end of the tether and configured to adjust tension in the flexible tether between the patient's mandible and tongue. Various anchors, tethers, securement mechanisms, and adjustment mechanisms that can be used with glossal and palatal remodeling systems are also disclosed.

Description

  • The present application which claims priority under 35 U.S.C. §119(e) claims priority to U.S. patent application Ser. No. 13/350,867, filed on Jan. 16, 2012, which claims priority under 35 U.S.C. §119(e) to U.S. patent application Ser. No. 11/835,931, filed on Aug. 8, 2007, which claims priority under 35 U.S.C. §119(e) to U.S. Provisional Application No. 60/836,579 filed on Aug. 8, 2006. The present application also claims priority under 35 U.S.C. §120 as a continuation-in-part of U.S. patent application Ser. No. 11/349,044, filed Feb. 7, 2006, which claims priority to U.S. Provisional Application Nos. 60/650,867 filed Feb. 8, 2005 and 60/726,028 filed Oct. 12, 2005. All of the priority applications are hereby incorporated by reference in their entirety.
  • BACKGROUND
  • 1. Field of the Invention
  • Certain embodiments of the present invention are related to methods and devices for the treatment of airway obstruction, such as, for example, obstructive sleep apnea, and devices and methods that facilitate insertion and retrieval of the same.
  • 2. Field of the Invention
  • This invention relates generally to a system and method for treating upper airway obstruction, sleep disordered breathing, upper airway resistance syndrome and snoring by manipulating the structures of the oropharynx, including the tongue.
  • 3. Description of the Related Art
  • Respiratory disorders during sleep are recognized as a common disorder with significant clinical consequences. During the various stages of sleep, the human body exhibits different patterns of brain and muscle activity. In particular, the REM sleep stage is associated with reduced or irregular ventilatory responses to chemical and mechanical stimuli and a significant degree of muscle inhibition. This muscle inhibition may lead to relaxation of certain muscle groups, including but not limited to muscles that maintain the patency of the upper airways, and create a risk of airway obstruction during sleep. Because muscle relaxation narrows the lumen of the airway, greater inspiratory effort may be required to overcome airway resistance. This increased inspiratory effort paradoxically increases the degree of airway resistance and obstruction through a Bernoulli effect on the flaccid pharyngeal walls during REM sleep.
  • Obstructive Sleep Apnea (OSA) is a sleep disorder that affects up to 2 to 4% of the population in the United States. OSA is characterized by an intermittent cessation of airflow in the presence of continued inspiratory effort. When these obstructive episodes occur, an affected person will transiently arouse, regain muscle tone and reopen the airway. Because these arousal episodes typically occur 10 to 60 times per night, sleep fragmentation occurs which produces excessive daytime sleepiness. Some patients with OSA experience over 100 transient arousal episodes per hour.
  • In addition to sleep disruption, OSA may also lead to cardiovascular and pulmonary disease. Apnea episodes of 60 seconds or more have been shown to decrease the partial pressure of oxygen in the lung alveoli by as much as 35 to 50 mm Hg. Some studies suggest that increased catecholamine release in the body due to the low oxygen saturation causes increases in systemic arterial blood pressure, which in turn causes left ventricular hypertrophy and eventually left heart failure. OSA is also associated with pulmonary hypertension, which can result in right heart failure.
  • Radiographic studies have shown that the site of obstruction in OSA is isolated generally to the supralaryngeal airway, but the particular site of obstruction varies with each person and multiple sites may be involved. A small percentage of patients with OSA have obstructions in the nasopharynx caused by deviated septums or enlarged turbinates. These obstructions may be treated with septoplasty or turbinate reduction procedures, respectively. More commonly, the oropharynx and the hypopharynx are implicated as sites of obstruction in OSA. Some studies have reported that the occlusion begins with the tongue falling back in an anterior-posterior direction (A-P) to contact with the soft palate and posterior pharyngeal wall, followed by further occlusion of the lower pharyngeal airway in the hypopharynx. This etiology is consistent with the physical findings associated with OSA, including a large base of tongue, a large soft palate, shallow palatal arch and a narrow mandibular arch. Other studies, however, have suggested that increased compliance of the lateral walls of the pharynx contributes to airway collapse. In the hypopharynx, radiographic studies have reported that hypopharyngeal collapse is frequently caused by lateral narrowing of the pharyngeal airway, rather than narrowing in the A-P direction.
  • OSA is generally diagnosed by performing overnight polysomnography in a sleep laboratory. Polysomnography typically includes electroencephalography to measure the stages of sleep, an electro-oculogram to measure rapid eye movements, monitoring of respiratory effort through intercostal electromyography or piezoelectric belts, electrocardiograms to monitor for arrhythmias, measurement of nasal and/or oral airflow and pulse oximetry to measure oxygen saturation of the blood.
  • Following the diagnosis of OSA, some patients are prescribed weight loss programs as part of their treatment plan, because of the association between obesity and OSA. Weight loss may reduce the frequency of apnea in some patients, but weight loss and other behavioral changes are difficult to achieve and maintain. Therefore, other modalities have also been used in the treatment of OSA, including pharmaceuticals, non-invasive devices and surgery.
  • Among the pharmaceutical treatments, respiratory stimulants and drugs that reduce REM sleep have been tried in OSA. Progesterone, theophylline and acetozolamide have been used as respiratory stimulants, but each drug is associated with significant side effects and their efficacy in OSA is not well studied. Protriptyline, a tricyclic antidepressant that reduces the amount of REM sleep, has been shown to decrease the frequency of apnea episodes in severe OSA, but is associated with anti-cholinergic side effects such as impotence, dry mouth, urinary retention and constipation.
  • Other modalities are directed at maintaining airway patency during sleep. Oral appliances aimed at changing the position of the soft palate, jaw or tongue are available, but patient discomfort and low compliance have limited their use. Continuous Positive Airway Pressure (CPAP) devices are often used as first-line treatments for OSA. These devices use a sealed mask which produce airflow at pressures of 5 to 15 cm of water and act to maintain positive air pressure within the pharyngeal airway and thereby maintain airway patency. Although CPAP is effective in treating OSA, patient compliance with these devices is low for several reasons. Sleeping with a sealed nasal mask is uncomfortable for patients. Smaller sealed nasal masks may be more comfortable to patients but are ineffective in patients who sleep with their mouths open, as the air pressure will enter the nasopharynx and then exit the oropharynx. CPAP also causes dry nasal passages and congestion.
  • Surgical treatments for OSA avoid issues with patient compliance and are useful for patients who fail conservative treatment. One surgery used for OSA is uvulopalatopharyngoplasty (UPPP). UPPP attempts to improve airway patency in the oropharynx by eliminating the structures that contact the tongue during sleep. This surgery involves removal of the uvula and a portion of the soft palate, along with the tonsils and portions of the tonsillar pillars. Although snoring is reduced in a majority of patients who undergo UPPP, the percentage of patients who experience reduced frequency of apnea episodes or improved oxygen saturation is substantially lower. Postoperatively, many patients that have undergone UPPP continue to exhibit oropharyngeal obstruction or concomitant hypopharyngeal obstruction. Nonresponders often have physical findings of a large base of tongue, an omega-shaped epiglottis and redundant aryepiglottic folds. UPPP is not a treatment directed at these structures. UPPP also exposes patients to the risks of general anesthesia and postoperative swelling of the airway that will require a tracheostomy. Excessive tissue removal may also cause velo-pharyngeal insufficiency where food and liquids enter into the nasopharynx during swallowing.
  • Laser-assisted uvulopalatopharyngoplasty (LAUP) is a similar procedure to UPPP that uses a CO2 laser to remove the uvula and portions of the soft palate, but the tonsils and the lateral pharyngeal walls are not removed.
  • For patients who fail UPPP or LAUP, other surgical treatments are available but these surgeries entail significantly higher risks of morbidity and mortality. In genioglossal advancement with hyoid myotomy (GAHM), an antero-inferior portion of the mandible, which includes the attachment point of the tongue musculature, is repositioned forward and in theory will pull the tongue forward and increase airway diameter. The muscles attached to the inferior hyoid bone are severed to allow the hyoid bone to move superiorly and anteriorly. Repositioning of the hyoid bone expands the retrolingual airspace by advancing the epiglottis and tongue base anteriorly. The hyoid bone is held in its new position by attaching to the mandible using fascia. Variants of this procedure attach the hyoid bone inferiorly to the thyroid cartilage.
  • A laser midline glossectomy (LMG) has also been tried in some patients who have failed UPPP and who exhibit hypopharyngeal collapse on radiographic studies. In this surgery, a laser is used to resect the midline portion of the base of the tongue. This involves significant morbidity and has shown only limited effectiveness.
  • In some patients with craniofacial abnormalities that include a receding mandible, mandibular or maxillomandibular advancement surgeries may be indicated for treatment of OSA. These patients are predisposed to OSA because the posterior mandible position produces posterior tongue displacement that causes airway obstruction. In a mandibular advancement procedure, the mandible is cut bilaterally posterior to the last molar and advanced forward approximately 10 to 14 mm. Bone grafts are used to bridge the bone gap and the newly positioned mandible is wire fixated to the maxilla until healing occurs. Mandibular advancement may be combined with a Le Fort I maxillary osteotomy procedure to correct associated dental or facial abnormalities. These procedures have a high morbidity and are indicated only in refractory cases of OSA.
  • Experimental procedures described in the clinical literature for OSA include the volumetric radiofrequency tissue ablation and hyoidplasty, where the hyoid bone is cut into several segments and attached to a brace that widens the angle of the U-shaped hyoid bone. The latter procedure has been used in dogs to increase the pharyngeal airway lumen at the level of the hyoid bone. The canine hyoid bone, however, is unlike a human hyoid bone because the canine hyoid bone comprises nine separate and jointed bones, while the human hyoid bone comprises five bones that are typically fused together.
  • Notwithstanding the foregoing, there remains a need for improved methods and devices for treating obstructive sleep apnea.
  • SUMMARY OF THE INVENTION
  • Methods and devices for manipulating tissue are provided. A tissue-tensioner is used to tension a region of tissue. The tissue tensioner is used to engage certain tissue of the body and apply tension to those tissues.
  • In further embodiments, methods and devices are disclosed for manipulating the tongue, or alternatively the soft palate. A tissue engaging structure can be positioned on the tongue, and the device is manipulated to displace at least a portion of the posterior tongue in an anterior or lateral direction, or to alter the tissue tension or compliance of the tongue.
  • In one embodiment, disclosed is a tissue tensioner for treating a condition of a patient's airway, said tissue tensioner including an elongate flexible tether having a first end and a second end; a bone anchor configured to be connected to a patient's mandible; and a tissue ingrowth implant configured to be implanted in a patient's tongue. The tissue ingrowth implant can be connected to the second end of the tether. The tissue tensioner can also include an adjustment mechanism configured to be held by the bone anchor adjacent the patient's mandible. The adjustment mechanism can be configured to receive the first end of the tether, as well as configured to adjust tension in the flexible tether between the patient's mandible and the patient's tongue. In some embodiments the elongate member can include either an active variable length tether or a coating tending to cause tissue ingrowth. The adjustment mechanism can include a rotational assembly such as a spool.
  • In one embodiment, disclosed is a tissue tensioner for treating a condition of a patient's airway, the tensioner including an elongate flexible tension member; a first portion of the tension member configured to be secured relative to a body tissue; and a second portion of the tension member including a tissue ingrowth material configured to be secured to a portion of a tongue; and an adjustment mechanism configured to adjust tension in the tension member between the body tissue and said portion of the tongue. In some embodiments the first portion of the tension member can be connected to either a bone anchor or a tissue anchor. In some embodiments the tissue ingrowth material is a single strand of woven material which may be partially covered by a cap element. The cap element can be radiopaque. The tension member can be beaded in some embodiments.
  • In one embodiment, a method for treating airway obstruction is disclosed. The method includes the steps of placing a tissue tensioner within a patient's tongue, the tensioner including a flexible elongate tension member having a first portion configured to be secured relative to a body tissue and a second portion that is connected to a tissue ingrowth material; an adjustment mechanism configured to adjust tension in the tension member between the body tissue and the tissue ingrowth material; securing the first portion relative to a body tissue and implanting the tissue ingrowth material within a portion of the tongue; and adjusting the tension of the tension member by manipulating the adjustment mechanism. In some embodiments the first portion is either secured relative to a patient's mandible using a bone anchor, or secured to tongue tissue using a tissue anchor. In some embodiments, the tissue ingrowth implant includes a single strand of woven material.
  • In another embodiment, disclosed is a tissue tensioner for treating a condition of a patient's airway, including an elongate flexible tension member comprising a first portion and a second portion; the first portion of the tension member being securable relative to a body tissue; the second portion being connected to a tissue ingrowth material; and means for adjusting the tension between the tissue ingrowth material and the body tissue. In some embodiments, the first portion of the tension member can be configured to be connected to either a bone anchor or a tissue anchor.
  • In another embodiment, disclosed is a tissue tensioner for treating a condition of a patient's airway that includes a flexible elongate tension member having a first portion and a second portion. The first portion can be securable relative to a body tissue, and the second portion can be connected to an implant including a single woven strand and configured to be implanted in a patient's tongue. A cap element can cover a portion of the woven implant.
  • In one embodiment, disclosed is a method for treating airway obstruction including the steps of deploying a tissue tensioner into a patient's tongue, the tissue tensioner including a flexible elongate tension member having a first portion secured relative to a body tissue and a second portion including a single strand woven implant that can be implanted in a patient's tongue. In some embodiments, the method also includes the step of removing the tissue tensioner from the patient by pulling on the single strand with sufficient force such that the woven implant unravels. The first portion may be secured either relative to the patient's mandible or within the patient's tongue.
  • In one embodiment, disclosed is a tissue tensioner for treating a condition of a patient's airway including a flexible elongate elastic member having a first portion and a second portion, wherein the first portion is configured to be secured relative to a body tissue and the second portion is connected to a tissue ingrowth material; and a locking bar releasably attached to the first portion and the second portion. The locking bar can be configured to prevent migration of the first portion relative to the second portion.
  • In one embodiment, disclosed is a method for treating a condition of a patient's airway, the method including the step of positioning a tissue tensioner within a patient. The tissue tensioner can include a flexible, elongate elastic member having a first portion secured relative to a body tissue and a second portion comprising a tissue ingrowth material implanted in a portion of the tongue. A locking bar is preferably releasably attached to the first portion and the second portion to prevent migration of the first portion with respect to the second portion. The locking bar can be manually pulled out to allow migration of the first portion with respect to the second portion.
  • In yet another embodiment, disclosed is a method for removing a tissue tensioner including the steps of providing a tissue tensioner, the tissue tensioner comprising a batten implant connected to a flexible tether; threading the flexible tether through a dilator; advancing the dilator over the flexible tether through tissue to the batten implant; advancing a cannula over dilator and over the implant; and removing the batten implant, the cannula, and the dilator. In some embodiments, at least a portion of the tissue ingrowth material is covered by a cap element.
  • In one embodiment, disclosed is a method for treating a condition of a patient's airway, including the steps of passing a first tension member through a patient's genioglossus muscle exiting the dorsum lateral to a midline of the patient's tongue creating a first exit hole; passing a second tension member through the patient's genioglossus muscle exiting the dorsum lateral to the midline of the patient's tongue creating a second exit hole; passing a sling element under the tongue surface though the first exit hole and the second exit hole; attaching the first tension member to a first portion of the sling; attaching the second tension member to a second portion of the sling; and securing first and second tension members relative to body tissue. In some embodiments the first and second tension members are secured to bone anchors.
  • In another embodiment, disclosed is a method for treating airway obstruction including the steps of placing a tissue tensioner within a patient's oral cavity, the tensioner including a flexible elongate tension member having a first portion configured to be secured relative to a body tissue and a second portion that is connected to a tissue ingrowth material; an adjustment mechanism configured to adjust tension in the tension member between the body tissue and the tissue ingrowth material; securing the first portion relative to a body tissue and implanting the tissue ingrowth material within a portion of the patient's soft palate; and adjusting the tension of the tension member by manipulating the adjustment mechanism. In some embodiments the first portion is secured relative to a patient's hard palate.
  • In still another embodiment, disclosed is a tissue tensioner for treating a condition of an airway, the tissue tensioner including: an elongate flexible tension member, a first portion of the tension member connected to a first tissue ingrowth material and a second portion of the tension member connected to a second tissue ingrowth material; and an adjustment mechanism configured to adjust tension in the tension member between the first tissue ingrowth material and the second tissue ingrowth material. In some embodiments the first tissue ingrowth material is implanted in a first body tissue and the second tissue ingrowth material is implanted in a second body tissue.
  • In yet another embodiment, disclosed is a method for treating airway obstruction, the method including placing a tissue tensioner within the tongue, the tensioner including a flexible elongate tension member having a first portion connected to a first tissue ingrowth material and a second portion connected to a second tissue ingrowth material; implanting the first tissue ingrowth material in a first portion of the tongue and implanting the second tissue ingrowth material in a second portion of the tongue; and adjusting the tension or length of the tension member by manipulating an adjustment mechanism configured to adjust tension in the tension member between the first tissue ingrowth material and the second tissue ingrowth material.
  • In another embodiment, disclosed is a tissue tensioner for treating a condition of a patient's airway, the tissue tensioner including an elongate flexible tension member, a first portion of the tension member including a tissue anchor configured to be secured to a first portion of a patient's tongue and a second portion of the tension member including a tissue ingrowth material configured to be secured to a second portion of the patient's tongue. The tissue anchor may include a fishbone anchor that has a plurality of barbs extending radially from the tension member.
  • In another embodiment, disclosed is a method for treating airway obstruction including placing a tissue implant within a patient's tongue or palate, the tissue implant comprising a multiple-pronged stiffening element; and expanding the stiffening element within the tongue or palate to stretch tissue laterally. The stiffening implant may have at least one, two, three, four, five, or more prongs.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 illustrates tongue and soft palate implants including adjustment elements to adjust the tension of a tether, according to one embodiment of the invention.
  • FIG. 2 is a schematic diagram showing one example of a securement assembly that may be used with a tongue or hyoid suspension system, according to one embodiment of the invention.
  • FIG. 3 shows tongue and soft palate implants comprising tethers with a beaded shape, according to one embodiment of the invention.
  • FIGS. 4A-C depict a tongue suspension system comprising a multi-piece sling, according to one embodiment of the invention.
  • FIG. 5 shows a tongue suspension system with an elongated member comprising a double-ended anchor, according to one embodiment of the invention.
  • FIGS. 6A-B illustrate an anchor with a plurality of barbs that may be self-expandable, according to one embodiment of the invention.
  • FIGS. 7A-B show an implant comprising a multi-pronged stiffening element, according to one embodiment of the invention.
  • FIGS. 8A-B illustrate a woven tissue implant that can be conveniently removed after implantation, according to one embodiment of the invention.
  • FIGS. 9A-C show a tissue implant that comprises a locking rod, according to one embodiment of the invention.
  • FIGS. 10A-C illustrate a recapture/removal tool for a batten-style implant, according to one embodiment of the invention.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • Causes of airway obstruction include but are not limited to obstructive sleep apnea, snoring and congenital disorders such as Pierre-Robin syndrome. Disclosed herein are various embodiments of devices or implants and methods for treating causes of airway obstruction. Embodiments described herein relate to, for example, adjustability, tethers, and anchors of those implants to treat said conditions. Also disclosed herein are methods and devices for deployment and retrieval of the implants disclosed. Some of such devices and methods are further described in co-pending application Ser. No. 11/349,040, filed Feb. 7, 2006, as well as in U.S. Patent Publication Nos. 2005/0092332 and 2005/0092334 to Conrad et al. (herein, “Conrad”), which are hereby incorporated by reference in their entirety. References to figures disclosed in Conrad herein refer to Publication No. 2005/0092334. In various embodiments, Conrad discloses implants and methods of using the implants to alter the geometry and position of the tongue and soft palate. Embodiments disclosed herein may also be adapted for use with the PILLAR® system of Restore Medical (St. Paul, Minn.).
  • U.S. patent application Ser. No. 11/349,040, filed Feb. 7, 2006 and published Sep. 14, 2006 as U.S. Patent Pub. No. 2006-0201519 A1 (“Frazier '519 publication”); U.S. Provisional Patent Application No. 60/813,230, filed Jun. 13, 2006 (“'230 provisional application”); U.S. Provisional Patent Application No. 60/813,285, filed Jun. 13, 2006 (“'285 provisional application); U.S. Patent Application No. 60/813,058, filed Jun. 13, 2006 (“'058 provisional application”); U.S. Patent Publication No. 2005/0092334 to Conrad et al (“Conrad”); U.S. Pat. No. 6,250,307 to Conrad et al. (“Conrad '307”); U.S. patent application Ser. No. 11/762,642 filed Jun. 13, 2007 (“Dineen '642 application”); U.S. patent application Ser. No. 11/762,752 filed Jun. 13, 2007 (“‘Hirotsuka '752 application”); and U.S. patent application Ser. No. 11/762,652 filed Jun. 13, 2007 (“Jackson '652 application”) are all incorporated by reference herein in their entirety.
  • Conrad discloses various methods and apparatuses for treating a condition of a patient's airway. FIG. 1 of Conrad illustrates an implant 10 that may be completely implanted within the tongue T, or alternatively, the soft palate SP. The implant 10 comprises an elongated member 12 having a tissue in-growth end 14 and a static end 16. In some embodiments, as shown in FIG. 3 of Conrad, the elongated member 12a may be resilient, e.g., in the form of a spring member which may be stretched to create a bias urging tissue in-growth 14a and static ends 16a of the spring together. In some embodiments, the implant may comprise a bioresorbable material 20 positioned between the tissue-engaging end 14a of the elongated member 12a and an anchor 18a. The tissue in-growth end 14a may be a tissue growth inducing material (e.g., felt or PET) to induce growth of tissue into the end to secure the end to surrounding tissue following implantation. An anchor 18a, positioned proximally (e.g., a threaded eye-bolt) is secured to the mandible JB for tongue implants, and the hard palate HP for soft palate SP implants 10′. The static end 16 of the elongated member 12 is secured to the anchor 18. The tissue in-growth end 14 is placed in the tongue T near the tongue base TB. A surgeon adjusts the tension of the suture 12, causing the tongue base TB to be advanced toward the mandible JB thereby placing the tissue of the tongue T in compression. The surgeon may tie off the static end 16 at the anchor 18 retaining the tissue of the tongue T under tension. Other anatomical structures shown include the trachea TR, epiglottis EP, esophagus ES, pharyngeal wall PW, trailing end of the soft palate TE, mouth M, and nasal cavity N.
  • In some embodiments, as shown in FIG. 11 of Conrad, tissue in-growth material 118 deployed proximally acts as an embedded anchor and eliminates the need for placement of an anchor in the mandible JB.
  • Adjustment Mechanisms
  • As noted above, FIG. 1 of Conrad illustrates an implant 10 that includes an elongated member 12 (also referred herein as a tether or a tension member) having a tissue in-growth end 14 and a static end 16. In some embodiments, as shown in FIG. 3 of Conrad, the elongated member may be resilient, e.g., in the form of a spring member 12a which may be stretched to create a bias urging tissue in-growth 14a and static ends 16a of the spring 12a together. In some embodiments, the implant 10a may comprise a bioresorbable material 20 positioned between the tissue-engaging end 14a of the elongated member 12a and an anchor 18a. The tissue in-growth end 14a may be a tissue growth inducing material (e.g., felt or PET) to induce growth of tissue into the end to secure the end to surrounding tissue following implantation.
  • In some embodiments, the devices discussed above can also include one or more adjustment elements, for example, one or more adjustment elements selected from those described in the Frazier '519 publication (e.g., those illustrated in FIGS. 61A-K of the Frazier '519 publication), the '230 provisional application (e.g., those illustrated in FIGS. 73-108 of the '230 provisional application), or the Dineen '642 application (e.g., those illustrated in FIGS. 73-98 of the Dineen '642 application). Adjustment elements can advantageously allow for adjusting the tension of the elongated member disclosed in Conrad after implantation of the tongue or palatal suspension system. A tongue or palatal remodeling system, device, and/or method for treating a patient with breathing problems that can be adjusted either before, during and/or after the initial implantation procedure may be better tolerated and less prone to treatment failure. For example, by being able to adjust the tension or bias of the elongated member disclosed in Conrad by methods other than by cutting and re-tying the elongated member at times other than during implantation, migration, extrusion, and/or dysphagia may be avoided or corrected.
  • For example, in one embodiment of the invention, shown schematically in FIG. 1 herein, the improved tongue suspension system 5020 includes one or more spools or rotation assemblies 5020, such as a spool assembly illustrated in FIGS. 61A to 61I of the Frazier '519 publication, for adjusting the tension of an elongated member 5012 between the mandibular anchor 5018 (attached to static end 5016 of the system) and the tissue in-growth end 5014 of the elongated member 5012, such as one disclosed in Conrad. A improved palatal suspension system 5030 is also shown in FIG. 1 that can be similar to the tongue suspension system, including one or more spools or rotation assemblies 5020′ for adjusting the tension of an elongated member 5012′ between a bone or hard palate anchor 5018′ (attached to static end 5016′ of the system) and the tissue in-growth end 5014 of the elongated member 5102′ attached to the soft palate. In some embodiments, the elongated member may be configured to adjust the tension between a soft tissue anchor and the tissue ingrowth end.
  • Securement Assemblies
  • In some embodiments, the aforementioned implants may include one or more securement mechanisms selected from those disclosed in disclosed in the Frazier '519 publication, (e.g., securement mechanisms illustrated in FIGS. 40-51 of the Frazier '519 publication) which may be configured for use a system such as the one disclosed in Conrad. For example, the bone anchor disclosed in Conrad may be replaced by a securement mechanism as disclosed in the Frazier '519 publication. The securement mechanism may be configured to hold the elongated member disclosed in Conrad or one or more tethers disclosed in, for example, the Frazier '519 publication or the Hirotsuka '752 application.
  • In one embodiment, illustrated schematically in FIG. 2, the tongue or soft palate implant such as one disclosed in Conrad includes a bone anchor 186 with a clamping interface 188 for retaining tethers 28, as illustrated in connection with FIGS. 40A-C of the Frazier '519 publication. The clamping interface 188 comprises two opposing surfaces 190, 192 or structures that are adapted to provide a frictional or mechanical interface with tethers 28 or other elongate members inserted within the clamping interface 188. The clamping interface 188 has an open configuration depicted in FIGS. 40A-C of the Frazier '519 publication to allow positioning of one or more tethers 28 within the interface 188 and a closed configuration shown for retaining the tethers 28. The closed configuration may be achieved by crimping the two opposing surfaces 190, 192 or by further structures of the clamping interface, such as complementary clasps or clip structures to fix the opposing surfaces 190, 192 together. As shown in FIG. 40C of the Frazier '519 publication, the clamping interface 188 may further comprise complementary indentations 194 and protrusions 196 to further enhance the frictional resistance of the interface in the closed configuration. The opposing surfaces or structures of the clamping interface may also be configured with frictional surfaces that are well known in the art through the use of various materials, surface treatments or configurations. Frictional surface configurations may also include cross hatched surfaces or irregular porous surfaces.
  • Tethers
  • As described above, Conrad teaches an elongated member having a tissue in-growth end and a static end. In some embodiments, as shown in FIG. 3 of Conrad, the elongated member 12a may be resilient, e.g., in the form of a spring member 12a which may be stretched to create a bias urging tissue in-growth 14a and static 16a ends of the spring together. An elongated member, such as one disclosed in Conrad may include any one of various tethers disclosed in the Frazier '519 publication (e.g., those illustrated in FIGS. 27-38 of the Frazier '519 publication), the '285 provisional application (e.g., those illustrated in FIGS. 73-84 of the '285 provisional application), or the Hirotsuka '752 application (e.g., those illustrated in FIGS. 73-80C of the Hirotsuka '752 application), and configured for use with the aforementioned Conrad tongue or palatal implants. A tether with elastic properties or comprising structures that provide a length/tension relationship may be preferred in some instances. A tether capable of lengthening in response to increased load or tension may be optimized to provide sufficient bias to reduce the effects of oropharyngeal occlusion while providing a more physiologic range of tongue or soft palate motion than that produced by fixed length tethers. Fixed length glossoplasty or suspension of the tongue may be the cause of odynophagia, dysphagia and deglutition problems seen with existing tongue remodeling devices, but the current invention is not limited to this purpose. A tether with elastomeric properties may be provided by using materials such as but not limited to urethane or silicone. One skilled in the art can select the particular material, tether length, diameter, cross-sectional shape and other features based upon the desired effect, tolerances, and the particular patient's anatomical characteristics. Other materials that may comprise the tether include but are not limited to Nitinol, spring steel, tantalum, polyethylene, polyester, silk, polypropylene, polyolefin or a combination thereof.
  • Other tether configurations that may be used include passive and active variable length or bias structures such as braided or woven structures, electropolymers, springs, coils, magnets or solenoids. Thus, in some of the embodiments, the tether configuration may actively change in length or configuration resulting from the application of external energy or force such as electrical current or magnets. These active tether configurations may be further configured with local or distal sensor components that may modulate the activity of the external energy or force acting on the active tether. The modulation may be influenced or triggered by detection of diaphragm movement or depolarization activity, nerve depolarization, pressure changes and/mechanical contact in the airway.
  • The tether may also be covered by a lubricious biocompatible coating. In another embodiment, the tether comprises a bioabsorbable coating that may cause scar or connective tissue formation about the tether. Scar tissue formation may further enhance the effect of the glossoplasty implant by tightening the tongue tissue (or similarly with regard to a palatal implant) and/or to resist migration of the implant.
  • In some embodiments, a tether of a tissue engaging member may be configured with one or more structures or surfaces capable of engaging at least a portion of the tissue surrounding the tether so that an anchor is not required, or to distribute the tissue engagement. In still other embodiments, the tissue engaging member may comprise multiple anchors and multiple tethers arranged in a serial or branching fashion.
  • FIG. 3 illustrates an embodiment of tongue 5050 and soft tissue 5050′ implants, both comprising a beaded tether 5040, 5040′, as disclosed in, for example, the Frazier '519 publication, the '285 provisional application, and the Hirotsuka '752 application. The beaded tether 5040, 5040′ may advantageously promote tissue in-growth and better tension the tongue 5050 or soft palate 5050′ suspension system. In other embodiments, one or more tethers selected from the tethers disclosed in the Frazier '519 publication, the '285 provisional application, or the Hirotsuka '752 application replace the elongated member disclosed in Conrad.
  • As illustrated in FIGS. 4A-4C, in one embodiment, an improved tongue suspension system 5060 comprises a tether further comprising one or more “sling” elements 5062 on a tongue or palate-based implant system such as disclosed in Conrad. The sling element 5062 may comprise, for example, a batten of porous fabric, woven material, a large diameter suture, braid, band, and the like. The sling element 5062 may be operably connected to, or replace the elongated member disclosed in Conrad. In some embodiments, the sling element 5062 comprises a central lumen configured to receive one or more sutures within the lumen. The sling element 5062 may alleviate trauma during installation of the tongue suspension system 5060 because the enlarged suture portion 5062 need not be passed through the entire tongue T. The sling 5062 can also advantageously increase anchoring surface area in the tongue T and prevent undesired migration of the elongated member.
  • A method of deploying an improved tongue suspension system 5060 comprising a sling element 5062 is disclosed herein, and illustrated in FIGS. 4A-4C. The method comprises the step of passing a first elongated member 5064 through the genioglossus muscle 5100 exiting the dorsum lateral to the midline. Next, a second elongated member 5066 is passed through the genioglossus muscle 5100 exiting the dorsum lateral to the midline on the contralateral side. Next, a sling element 5062 is passed under the tongue T surface between exit holes created from the passing of the first 5064 and second 5066 elongated members through the genioglossus muscle 5100. Then, elongated members 5064, 5066, such as sutures are attached to each end of the sling element 5062. In some embodiments with a sling element 5062 that further include a lumen, the portion of the elongated member within the sling element may be secured within the lumen of the sling element 5062. The elongated members 5064, 5066 outside of the sling element may then be attached to the bone anchor 5068. In another embodiment, the sling element 5062 is formed during the procedure by passing a plurality of sutures transversely through the tongue along different pathways. The ends of the sutures located to each side of the midline tongue are then joined together to form the ends of the sling element. The in situ formed sling element can then be attached to the first and second sutures as described above.
  • Tissue Engagement
  • As described above, Conrad teaches an elongated member having a tissue in-growth end. In some embodiments, as described with reference to FIG. 11 Of Conrad, the elongated member 12 has two tissue in-growth ends (e.g., felt or PET); a proximal in-growth end 118 acting as an embedded anchor eliminating the need for placing an anchor in the mandible, and a distal in-growth end 14 for tensioning the tongue suspension system. In one embodiment of the present invention, a tongue suspension system comprises an implant with one or more anchors selected from the anchors disclosed in the Frazier '519 publication (e.g., as illustrated in FIGS. 7-26 of the Frazier '519 publication), the '058 provisional application (e.g., as illustrated in FIGS. 73-112 of the '058 provisional application), or the Jackson '652 application replacing the one or more tissue in-growth ends of a tongue or palatal implant disclosed in Conrad. The anchors can advantageously improve tongue or palatal suspension by providing a greater surface area and resistance to migration of the implant. For example, in one embodiment as illustrated schematically in FIG. 5 herein, the tissue in-growth ends may comprise double-ended anchors 5080 as illustrated, for example, in FIGS. 86-112 of the '058 provisional application, or the anchors of the Jackson '652 application. The anchor may be operably connected to the elongated member as disclosed in Conrad, or a tether as disclosed in the Frazier '519 application, '058 provisional application, or the Jackson '652 application as noted above. Other tissue ingrowth materials that may be used include polypropylene, polytetrafluoroethylenes, polyurethanes, polyesters, ceramics, porous metals or combinations thereof. In some embodiments, bioglues may be used to facilitate tissue adhesion to the implant. Bioglues may be injected at the implantation site or provided as a coating on the implant. A bioglue coating may provided at the point of manufacture or the point of service. In some embodiments, a tongue suspension system may include a first tissue ingrowth portion and a second tissue ingrowth portion, connected by a flexible elongate tether. The length and/or tension of the tether can be adjusted using an adjustment mechanism described herein, for example, a spool.
  • In some embodiments as shown in FIG. 5, soft palate implants, such as those disclosed in Conrad may include one or more anchors 5082′ selected from those disclosed in the Frazier '519 publication (e.g., FIGS. 63-69 of the Frazier '519 publication) replacing the one or more tissue ingrowth ends of the expandable member, for example, as illustrated in Conrad FIGS. 1-2.
  • Another embodiment of an improved tongue or palatal suspension system comprises one or more tissue-engaging anchors 5090 as illustrated schematically in FIGS. 6A-B herein. The anchor 5090 may be deployed distally, proximally, or both distally and proximally (relative to the position of the tongue or the palate), and connected by a tether that is preferably elongate and flexible in some embodiments. The anchor 5090 may optionally comprise a plurality of “fish bone” shaped barbs 5092 in series extending radially out from and operably connected at one end to the anchor 5090 as illustrated. The angles of the barbs 5092 when fully deployed may range anywhere from about 0 degrees to about 180 degrees with respect to vector of insertion, preferably about 45 degrees to 135 degrees, and most preferably about 60 degrees to about 150 degrees. The angles of the barbs 5092 may be uniform or non-uniform along the length of the implant 5090. Although the barbs 5092 in FIGS. 6A-B are arranged in pairs within a common plane of orientation, in other embodiments the barbs 5092 may be unpaired and/or circumferentially arranged. The barbs 5092 may be made of Nitinol, other metals, one or more polymers, or other suitable material. In some embodiments, the barbs 5092 may be bioabsorbable to decrease tissue irritation as well as to facilitate tissue ingrowth. In some embodiments, at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or more barbs may be present. The anchor 5090 may be predeployed in a first, collapsed configuration, as schematically illustrated in FIG. 6A within a delivery tube (not shown). Upon removal of the delivery tube, for example, within the genioglossus muscle, the barbs 5092 spring outward to engage the tissue, as shown in FIG. 6B. The anchor 5090 may be attached to an adjustable securement assembly as described above and disclosed in the Frazier '519 publication. The adjustability is especially advantageous when the anchor 5090 is placed untensioned, and tensioned at a later time after a healing and tissue ingrowth period. The anchor 5090 disclosed herein may also be configured for use for soft palate implants as disclosed in Conrad, as well as Conrad '307.
  • Conrad discloses several implants to stiffen the base of the tongue and resist floppy action or lack of tone in the tissue of the tongue near the base. For example, FIG. 8 of Conrad illustrates contracting implants 40 that may be placed in the tongue T in-line with radiating lines A of certain muscles of the tongue (e.g., genioglossus muscles). As the implants 40 contract over time, they urge the tongue T from collapsing toward the pharyngeal wall PW. FIG. 12-13 of Conrad illustrates implants 120 spaced apart for fibrosis to interconnect between the implants 120. FIGS. 14-17 of Conrad illustrate the use of embedded crimps or staples 150 to stiffen and potentially illustrate the tongue base. In the embodiments shown in FIGS. 14-15, the crimps 150 are slightly curved members which are placed in the tongue with concave surfaces opposing the tongue base. The crimping acts to squeeze tissue of the tongue to stiffen the tongue.
  • In another embodiment, of the invention, disclosed is a multi-pronged stiffening element 5100, schematically illustrated implanted in a soft palate herein in FIGS. 7A-B. The stiffening element 5100 may have at least about two, three, four, five or more prongs and be implanted, for example, in the tongue, palate, and the like. The stiffening element 5100 increases stiffness within the implanted tissue by stretching the tissue in one or more directions. In some embodiments, the tissue is stretched laterally. In some embodiments, the stiffening element 5100 is trident-shaped as shown. However, one of ordinary skill in the art will appreciate that many other possible shapes are possible. The stiffening element may be expandable after delivery.
  • Recapturability
  • FIGS. 8A-B illustrate an embodiment of an improved woven tissue implant 5104 that can advantageously be easily removed, from, e.g., the tongue or the soft palate. The implant 5104 may be a batten type stiffener or tissue anchor formed from a single strand. The single strand can be woven or knitted into a desired shape, for example, a rod-like structure. The woven tissue implant 5104 may be deployed into tissue to stiffen a particular area and serve a similar function to the implants illustrated in FIGS. 8 and 12-17 of Conrad or implants of the PILLAR® system (Restore Medical), or attached to one or more tethers for use as a tissue anchor or sling. The woven design facilitates tissue ingrowth within the spaces around the woven implant 5014, effectively increasing the surface area of the implant 5104 and increasing the implant's anchoring force. The implant 5104 is most preferably configured to have sufficient structural integrity necessary to anchor tissue. However, the woven implant 5104 is also preferably configured such that pulling on an end of the single strand of the implant with an appropriate force will unwind or unravel the implant 5104 into a long filament (as shown in FIG. 8B) for simple and convenient removal of the implant. The appropriate force required to unwind the implant 5104 is most preferably sufficiently greater than the tensioning force of the tissue on the implant 5104 while deployed in the tongue, palate, or surrounding tissue so that the implant 5104 does not undesirably unwind while deployed. Part or all of the implant 5104 may include a radiopaque marker material.
  • As illustrated in FIG. 3 of Conrad, the implant may comprise a bioresorbable material 20 positioned between the tissue-engaging end 14a of the elongated member 12a and an anchor 16a. The bioresorbable material 20 may oppose a spring member 12a which may be stretched to create a bias urging ends 14a, 16a of the elongated member 12a toward one another. The bioresorbable material 20 positioned between the tissue-engaging end 14a and a bolt 18a will later resorb into the tissue of the tongue T permitting the end to be urged toward the bolt 18a by the resilience of the spring 12a, tensioning the device.
  • FIG. 9 herein illustrates an improved embodiment of a tether 5108 that may be used with tissue ingrowth implants, such as, for example, those disclosed in Conrad. An improved tether 5108 comprises a locking bar 5112 releasably attached to both the tissue ingrowth end 5014 and the bone anchor 5018 (or both tissue ingrowth ends in some embodiments) and disposed within an elastic member 5110. The elastic member 5110 is preferably connected to an implant or anchor 5014 (such as the tissue ingrowth engaging member of Conrad) at a first end and a securing element 5018 (such as a bone anchor) or another tissue anchor at a second end. The locking bar 5112 may comprise one or more forked or capped ends 5113. The locking bar 5112 may comprise metal, polymer, or other biocompatible material, but preferably has a relatively low elasticity to prevent migration of the implant or anchor 5014 in the acute post-implantation period. During this period, there may be inadequate tissue ingrowth for the implant or anchor 5014 to provide a sufficient anchoring force to tension the tether 5110. Other tethers that can also be used to provide a temporary or permanent anchoring force are disclosed in, for example, the Frazier '519 publication, the '285 provisional application, and the Hirotsuka '752 application.
  • The locking bar 5112 provides the appropriate anchoring force until adequate tissue ingrowth occurs and the elastic member 5110 can be appropriately tensioned (as an alternative, for example, to the bioresorbable material solution illustrated in FIG. 3 of Conrad). When adequate tissue ingrowth occurs, the locking bar 5112 may be removed via a recapture tool as disclosed elsewhere in the application and the Frazier '519 publication (e.g., at FIGS. 70-72 of the Frazier '519 publication). The locking bar 5112 can be accessed via a surgical procedure and pulled out manually. In other embodiments, the locking bar 5112 may comprise a tether line running to the bone anchor 5018 which can be used with a percutaneous recapture system, such as the system disclosed in the Frazier '519 publication, for removal. A dilator tool can follow the tether to an end of the locking bar 5112, and the locking bar 5112 could then be pulled out. If the locking bar 5112 is made from a smooth material (e.g., a metal or plastic rod) the tether line can be pulled directly to remove the bar without the need for a dilator tool. In some embodiments, the locking bar 5112 may be made of a biodegradable material, such as polylactic acid, polyglycolic acid and the like, that degrades at a rate slow enough to continue to provide anchoring force to the implant 5014 until adequate tissue ingrowth allows the elastic member 5110 to be appropriately tensioned.
  • Various devices and methods to promote recapturability and removal of a batten implant, such as, for example, implants illustrated in FIGS. 8 and 12-17 of Conrad, implants disclosed in U.S. Pat. No. 6,250,307 to Conrad et al., and the PILLAR® System (Restore Medical) are disclosed. An improved batten-style implant 5120, illustrated in FIGS. 10A-C herein, comprises one or more cap elements 5122. The cap elements 5122 are preferably attached to the proximal end, distal end, or both ends of the batten implant. In some embodiments, the cap element 5122 covers a substantial portion, or even the entire batten implant 5120. The cap element 5122 may be made of, for example, plastic, metal, Dacron, ePTFE, and the like. In some embodiments, the cap element 5122 comprises radiopaque material such that the cap 5122 can be visualized on plain film radiographs. In other embodiments, the cap element 5122 comprises material that can be visualized on ultrasound, magnetic resonance imaging, or other imaging modalities.
  • The cap elements 5122 can advantageously assist in guiding an implant removal device, such as a cannula 5124, onto the main body of the implant 5120 such that the cutting edges of the removal device 5124 can separate the fibrous encapsulation near the implant surface without cutting into, or otherwise damaging the implant body 5120. The cap elements 5122 may be especially advantageous when the implant 5120 is tethered, for example, when the implant 5120 is used as a tissue anchor to apply traction to the tongue or the palate. Thus, the cap elements 5122 may allow the batten implant 5120 to readily and safely removed from tissue while minimizing tissue trauma and reducing the risk of damage to the implant 5120 complicating removal through increased force or cutting or tearing of the implant 5120.
  • A method for recapturing a batten implant 5120 will be described. First, trailing sutures 5012 are threaded through a dilator with a cannula assembly 5124, such as a recapture tool depicted in FIGS. 7G to 7J and FIGS. 70-72 of the Frazier '519 publication. Next, the cannula and dilator 5124 (shown schematically as a single cannula for simplicity in FIGS. 10B-C) are advanced over the sutures 5012 and through tissue to the batten implant 5120. In batten implant 5120 embodiments that comprise an imaging marker, the cannula and dilator 5124 may be guided by, for example, an appropriate technique to detect the imaging marker, such as fluoroscopy, ultrasound, CT, MRI, and the like. Fibrous tissue may be dissected from the sutures 5012 using the dilator 5124. Then, in embodiments of implants 5120 that comprise one or more cap elements 5122, the cannula 5124 is advanced over the implant 5120 when the dilator 5124 reaches the cap element 51. The cap element 5122 is preferably configured to be harder in texture than the surrounding peri-implant fibrous tissue, allowing the cannula 5124 to be guided over the implant body 5120 without cutting the softer material of the implant body. Next, the implant 5120 and recapture assembly 5124 is removed.
  • Delivery Systems
  • The various embodiments disclosed in Conrad as well as the embodiments of the present invention disclosed herein may be deployed within a delivery system, such as the delivery system disclosed in the Frazier '519 publication (e.g., the delivery system illustrated in FIGS. 62A-D of the Frazier '519 publication). In one embodiment, as illustrated in FIGS. 62B-C of the Frazier '519 publication, a delivery tool comprises a pushrod attached to an actuator handle, the pushrod having a distal position and a proximal position which can be manipulated by a user through the actuator handle. An implant comprising a tissue ingrowth end, static end, and an elongated member, therebetween, such as, for example, an implant illustrated in FIGS. 1-4 of Conrad, may be loaded into the delivery tool by attaching the end(s) of the elongated member to an attachment site on a spool within the delivery tool. When the elongated member is attached to the spool and the dial attached to the spool is rotated, the elongated member, including the tissue ingrowth end, are pulled into the tubular body as the elongated member is wound around the spool. The proximal pulling of the tissue ingrowth end into the delivery tube causes the tissue ingrowth end to retract into a relatively compact delivery profile configuration and into the tubular body. When the actuator handle is moved from the loading position to the deployed position, the actuator handle overcomes the bias of the resistance structure to release the rotation resistance. This allows the spool to freely rotate and to quickly deploy the tissue ingrowth end, followed by the rest of the elongated member, into the tissue. The speed with which the tissue ingrowth end is deployed may affect the degree of tissue engagement by the tissue ingrowth end. In some instances, it is desirable to reduce rotation resistance in the delivery phase compared to the loading phase of the delivery tool usage.
  • While this invention has been particularly shown and described with references to embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention. For example, in some embodiments, a tongue or soft palate implant may have one or more elements of different embodiments described herein, for example, one or more anchors disclosed in the Frazier '519 publication, '058 provisional application, or Jackson '652 application and one or more adjustment elements described in the Frazier '519 publication, '230 provisional application, or the Dineen '642 application. Furthermore, the invention encompasses other combinations of any or all of the disclosures of the aforementioned references. For all of the embodiments described above, the steps of the methods need not be performed sequentially.

Claims (2)

1. A tissue tensioner for treating a condition of a patient's airway comprising:
a flexible, elongate elastic member having a first portion and a second portion, wherein the first portion is configured to be secured relative to a body tissue and the second portion is connected to a tissue ingrowth material; and
a locking bar releasably attached to the first portion and the second portion, the locking bar configured to prevent migration of the first portion relative to the second portion.
2. A method for treating a condition of a patient's airway, the method comprising:
positioning a tissue tensioner within a patient, the tissue tensioner comprising a flexible, elongate elastic member having a first portion secured relative to a body tissue and a second portion comprising a tissue ingrowth material implanted in a portion of the tongue, wherein a locking bar is releasably attached to the first portion and the second portion to prevent migration of the first portion with respect to the second portion; and
manually pulling out the locking bar to allow migration of the first portion with respect to the second portion.
US14/312,218 2005-02-08 2014-06-23 Airway implants and methods and devices for insertion and retrieval Abandoned US20150075541A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US65086705P 2005-02-08 2005-02-08
US72602805P 2005-10-12 2005-10-12
US11/349,044 US20060207606A1 (en) 2005-02-08 2006-02-07 Method for adjusting tissue anchors
US83657906P 2006-08-08 2006-08-08
US11/835,931 US8096303B2 (en) 2005-02-08 2007-08-08 Airway implants and methods and devices for insertion and retrieval
US13/350,867 US8757163B2 (en) 2005-02-08 2012-01-16 Airway implants and methods and devices for insertion and retrieval

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/350,867 Division US8757163B2 (en) 2005-02-08 2012-01-16 Airway implants and methods and devices for insertion and retrieval

Publications (1)

Publication Number Publication Date
US20150075541A1 true US20150075541A1 (en) 2015-03-19

Family

ID=46329130

Family Applications (3)

Application Number Title Priority Date Filing Date
US11/835,931 Expired - Fee Related US8096303B2 (en) 2005-02-08 2007-08-08 Airway implants and methods and devices for insertion and retrieval
US13/350,867 Expired - Fee Related US8757163B2 (en) 2005-02-08 2012-01-16 Airway implants and methods and devices for insertion and retrieval
US14/312,218 Abandoned US20150075541A1 (en) 2005-02-08 2014-06-23 Airway implants and methods and devices for insertion and retrieval

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US11/835,931 Expired - Fee Related US8096303B2 (en) 2005-02-08 2007-08-08 Airway implants and methods and devices for insertion and retrieval
US13/350,867 Expired - Fee Related US8757163B2 (en) 2005-02-08 2012-01-16 Airway implants and methods and devices for insertion and retrieval

Country Status (1)

Country Link
US (3) US8096303B2 (en)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7128073B1 (en) 1998-11-06 2006-10-31 Ev3 Endovascular, Inc. Method and device for left atrial appendage occlusion
US7419949B2 (en) * 2001-07-16 2008-09-02 Novo Noridsk Healthcare A/G Single-dose administration of factor VIIa
US7965719B2 (en) * 2002-12-11 2011-06-21 Broadcom Corporation Media exchange network supporting multiple broadband network and service provider infrastructures
US7992567B2 (en) 2005-02-08 2011-08-09 Koninklijke Philips Electronics N.V. System and method for percutaneous glossoplasty
US8096303B2 (en) * 2005-02-08 2012-01-17 Koninklijke Philips Electronics N.V Airway implants and methods and devices for insertion and retrieval
US8371307B2 (en) 2005-02-08 2013-02-12 Koninklijke Philips Electronics N.V. Methods and devices for the treatment of airway obstruction, sleep apnea and snoring
US7644714B2 (en) * 2005-05-27 2010-01-12 Apnex Medical, Inc. Devices and methods for treating sleep disorders
US20090173351A1 (en) * 2006-04-20 2009-07-09 Pavad Medical, Inc. Control system for a tongue stabilization device
US7909038B2 (en) * 2006-04-20 2011-03-22 Pavad Medical, Inc. Tongue stabilization device and methods of using the same
US8256425B2 (en) * 2006-04-20 2012-09-04 Medtronic Xomed, Inc. Methods and devices for removal of a tongue stabilization device
US7909037B2 (en) * 2006-04-20 2011-03-22 Pavad Medical Tethered airway implants and methods of using the same
WO2009072115A2 (en) * 2007-12-05 2009-06-11 Svip 7 Llc Devices and methods for treating sleep disordered breathing
US8167787B2 (en) * 2008-01-03 2012-05-01 Revent Medical, Inc. Partially erodable systems for treatment of obstructive sleep apnea
US8733363B2 (en) * 2010-03-19 2014-05-27 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US9439801B2 (en) * 2012-06-29 2016-09-13 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US20140007885A1 (en) * 2012-07-06 2014-01-09 Edward M. Gillis Systems and methods for treatment of sleep apnea
WO2009140197A1 (en) 2008-05-12 2009-11-19 Revent Medical, Inc. Partially erodable systems for treatment of obstructive sleep apnea
US8678008B2 (en) * 2008-07-30 2014-03-25 Ethicon, Inc Methods and devices for forming an auxiliary airway for treating obstructive sleep apnea
US8556797B2 (en) 2008-07-31 2013-10-15 Ethicon, Inc. Magnetic implants for treating obstructive sleep apnea and methods therefor
US8413661B2 (en) * 2008-08-14 2013-04-09 Ethicon, Inc. Methods and devices for treatment of obstructive sleep apnea
US8561616B2 (en) 2008-10-24 2013-10-22 Ethicon, Inc. Methods and devices for the indirect displacement of the hyoid bone for treating obstructive sleep apnea
US8561617B2 (en) * 2008-10-30 2013-10-22 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US8800567B2 (en) 2008-12-01 2014-08-12 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US8783258B2 (en) 2008-12-01 2014-07-22 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
ATE551035T1 (en) * 2008-12-30 2012-04-15 Medartis Ag IMPLANT FOR THE TREATMENT OF OBSTRUCTIVE SLEEP APNOESYNDROME
US8371308B2 (en) 2009-02-17 2013-02-12 Ethicon, Inc. Magnetic implants and methods for treating an oropharyngeal condition
US8555891B2 (en) * 2009-02-18 2013-10-15 Medtronic Xomed, Inc. Implant system for controlling airway passage
US8307831B2 (en) 2009-03-16 2012-11-13 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US9326886B2 (en) 2009-10-29 2016-05-03 Ethicon, Inc. Fluid filled implants for treating obstructive sleep apnea
US9877862B2 (en) * 2009-10-29 2018-01-30 Ethicon, Inc. Tongue suspension system with hyoid-extender for treating obstructive sleep apnea
US9974683B2 (en) * 2009-10-30 2018-05-22 Ethicon, Inc. Flexible implants having internal volume shifting capabilities for treating obstructive sleep apnea
WO2011068952A1 (en) * 2009-12-02 2011-06-09 Entrigue Surgical, Inc. Devices for tongue stabilization
US8632488B2 (en) 2009-12-15 2014-01-21 Ethicon, Inc. Fluid filled implants for treating medical conditions
WO2011079222A2 (en) 2009-12-23 2011-06-30 Boston Scientific Scimed, Inc. Less traumatic method of delivery of mesh-based devices into human body
WO2011116382A2 (en) * 2010-03-19 2011-09-22 Revent Medical Inc. Systems and methods for treatment of sleep apnea
US8460322B2 (en) 2010-03-31 2013-06-11 Siesta Medical, Inc. Suture passer systems and methods for tongue or other tissue suspension and compression
AU2011255195A1 (en) * 2010-05-21 2012-11-29 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
WO2011146926A2 (en) * 2010-05-21 2011-11-24 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US9833353B2 (en) * 2010-06-03 2017-12-05 Koninklijke Philips N.V. Glossoplasty implant tension relief system
JP2013538075A (en) * 2010-07-26 2013-10-10 レベント メディカル インコーポレイテッド System and method for treating sleep apnea
WO2012075186A2 (en) * 2010-11-30 2012-06-07 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
EP2667811B1 (en) 2011-01-27 2015-12-30 Cryosa, Llc Apparatus for treatment of obstructive sleep apnea utilizing cryolysis of adipose tissues
EP3028683B1 (en) 2011-07-14 2018-05-09 Cook Medical Technologies LLC A kit to be used in the treatment of obstructive sleep apnea
US8905033B2 (en) 2011-09-28 2014-12-09 Ethicon, Inc. Modular tissue securement systems
US9161855B2 (en) 2011-10-24 2015-10-20 Ethicon, Inc. Tissue supporting device and method
US8973582B2 (en) 2011-11-30 2015-03-10 Ethicon, Inc. Tongue suspension device and method
US10470760B2 (en) 2011-12-08 2019-11-12 Ethicon, Inc. Modified tissue securement fibers
EP2790764A4 (en) 2011-12-15 2015-06-03 Univ Leland Stanford Junior Devices and methods for preventing tracheal aspiration
US9173766B2 (en) 2012-06-01 2015-11-03 Ethicon, Inc. Systems and methods to treat upper pharyngeal airway of obstructive sleep apnea patients
WO2014039848A1 (en) 2012-09-07 2014-03-13 Siesta Medical, Inc. Tether line systems and methods for tongue or other tissue suspension or compression
CA2888030A1 (en) * 2012-10-16 2014-11-27 Cook Medical Technologies Llc Method and apparatus for treating obstructive sleep apnea (osa)
AU2013376536A1 (en) 2013-02-04 2015-01-15 Xiangmin Zhang Tongue back elastic traction apparatus, holding clamp, mounting clamp, thread guiding apparatus, and implanting method
US9480594B2 (en) * 2013-02-27 2016-11-01 Spirox, Inc. Nasal implants and systems and methods of use
US10123900B2 (en) 2013-03-15 2018-11-13 Cook Medical Technologies Llc Devices, kits, and methods for the treatment of obstructive sleep apnea
WO2014140777A1 (en) * 2013-03-15 2014-09-18 Füglister Fabian Hermann Urban Tongue deformation implant
CA2919504A1 (en) 2013-08-01 2015-02-05 Christine BRONIKOWSKI Tissue adjustment implant
AU2014306232B2 (en) 2013-08-05 2018-12-06 Cook Medical Technologies Llc Medical devices having a releasable tubular member and methods of using the same
EP3065804A4 (en) 2013-11-05 2017-08-16 Ciel Medical, Inc. Devices and methods for airway measurement
CN104906682A (en) 2014-01-24 2015-09-16 史蒂文·沙勒布瓦 Articulating balloon catheter and method for using the same
US20150250476A1 (en) 2014-03-05 2015-09-10 Siesta Medical, Inc. Systems and methods for tissue suspension and compression
US9974563B2 (en) 2014-05-28 2018-05-22 Cook Medical Technologies Llc Medical devices having a releasable member and methods of using the same
EP3177219B1 (en) 2014-08-04 2018-09-26 Cook Medical Technologies LLC Medical devices having a releasable tubular member
CN105476741A (en) * 2014-09-14 2016-04-13 张湘民 Implant used for building tunnel under dorsum mucous membrane
US11534335B2 (en) 2014-10-01 2022-12-27 Cryosa, Inc. Apparatus and methods for treatment of obstructive sleep apnea utilizing cryolysis of adipose tissues
GB2551202A (en) * 2016-06-10 2017-12-13 Univ Cape Town Implantable device
US11147574B2 (en) * 2016-10-04 2021-10-19 Erik S. Kass Suspension uvulopalatopexy related methods, devices, and apparatuses
EP3644911A1 (en) 2017-06-29 2020-05-06 Cook Medical Technologies, LLC Implantable medical devices for tissue repositioning
US11554027B2 (en) 2018-09-10 2023-01-17 Siesta Medical, Inc. Systems and methods for nasal support

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7213599B2 (en) * 2003-10-31 2007-05-08 Restore Medical, Inc. Airway implant

Family Cites Families (266)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US346771A (en) 1886-08-03 Turn buckle
US1156440A (en) 1915-01-29 1915-10-12 John X Smith Fracture-clamp.
US1374963A (en) 1918-03-15 1921-04-19 Safety Nut & Bolt Company Turnbuckle
US2154428A (en) 1937-04-10 1939-04-18 Automatic Instr Company Vibrator heater
US2181746A (en) 1939-02-04 1939-11-28 John R Siebrandt Combination bone clamp and adjustable drill guide
US2583896A (en) 1949-09-06 1952-01-29 Siebrandt Inc Bone clamp
US2824717A (en) 1953-12-21 1958-02-25 James O Yeager Attaching means for load binder or boomer
US2966907A (en) 1956-08-16 1961-01-03 Peter A Fasolino Bone clamps
DE1242322B (en) 1964-09-08 1967-06-15 Sorenson Res Corp Tongue holder
US3477429A (en) 1967-06-30 1969-11-11 Sampson Corp Extra-cortical clamp with detachable tensioning tool for internal fixation of bone fractures
US3593709A (en) 1968-10-28 1971-07-20 William X Halloran Angular compression plate for bone fractures
US5141581A (en) * 1972-10-08 1992-08-25 Markham Harold A Implants with a cover which resists formation of firm spherical encapsulation
FR2416683A1 (en) 1978-02-10 1979-09-07 Judet Robert IMPROVEMENTS TO OSTEO-SYNTHESIS DEVICES
US4279248A (en) 1979-07-20 1981-07-21 Shlomo Gabbay Sternum closure device and procedure for using same
US4348179A (en) 1981-05-01 1982-09-07 Francesco Pedrazzini Adjustable orthodontic screw assembly
US4366815A (en) 1981-06-04 1983-01-04 Broomes Edward L C Anti-snoring apparatus
US5601557A (en) 1982-05-20 1997-02-11 Hayhurst; John O. Anchoring and manipulating tissue
US6656182B1 (en) 1982-05-20 2003-12-02 John O. Hayhurst Tissue manipulation
US5190546A (en) 1983-10-14 1993-03-02 Raychem Corporation Medical devices incorporating SIM alloy elements
US4700697A (en) 1985-05-09 1987-10-20 Mundell Robert D Cervical appliance to ameliorate sleep apneas
US4676240A (en) 1985-09-09 1987-06-30 Gardy Victor R Tongue locking device to minimize effects of sleep apnea and to reduce snoring
US4840172A (en) 1986-09-04 1989-06-20 Augustine Scott D Device for positioning an endotracheal tube
US4830008A (en) 1987-04-24 1989-05-16 Meer Jeffrey A Method and system for treatment of sleep apnea
US5478353A (en) 1987-05-14 1995-12-26 Yoon; Inbae Suture tie device system and method for suturing anatomical tissue proximate an opening
US4898156A (en) 1987-05-18 1990-02-06 Mitek Surgical Products, Inc. Suture anchor
CN1009154B (en) 1987-06-08 1990-08-15 周崇林 Bone fracture internal fixing device
US4858601A (en) 1988-05-27 1989-08-22 Glisson Richard R Adjustable compression bone screw
US4885824A (en) 1988-09-02 1989-12-12 Leonard M. Schwab Adjustable tension fastener
JP2794196B2 (en) 1989-06-20 1998-09-03 チェスト株式会社 Apnea prevention stimulator
US4978323A (en) 1989-08-10 1990-12-18 George Freedman System and method for preventing closure of passageways
US5176618A (en) 1989-08-10 1993-01-05 George Freedman System for preventing closure of passageways
US5176617A (en) 1989-12-11 1993-01-05 Medical Innovative Technologies R & D Limited Partnership Use of a stent with the capability to inhibit malignant growth in a vessel such as a biliary duct
US6464713B2 (en) 1990-06-28 2002-10-15 Peter M. Bonutti Body tissue fastening
US5593425A (en) 1990-06-28 1997-01-14 Peter M. Bonutti Surgical devices assembled using heat bonable materials
US7208013B1 (en) 1990-06-28 2007-04-24 Bonutti Ip, Llc Composite surgical devices
US6203565B1 (en) 1990-06-28 2001-03-20 Peter M. Bonutti Surgical devices assembled using heat bondable materials
US5127413A (en) 1990-08-09 1992-07-07 Ebert Edward A Sinous suture
US5123425A (en) 1990-09-06 1992-06-23 Edentec Obstructive sleep apnea collar
US5282845A (en) 1990-10-01 1994-02-01 Ventritex, Inc. Multiple electrode deployable lead
ATE176998T1 (en) 1991-12-03 1999-03-15 Boston Scient Ireland Ltd INSTRUMENT FOR PASSING A SEWING THREAD
US5254097A (en) 1992-01-06 1993-10-19 Datascope Investment Corp. Combined percutaneous cardiopulmonary bypass (PBY) and intra-aortic balloon (IAB) access cannula
GB9206018D0 (en) 1992-03-19 1992-04-29 Dall Desmond Meiring Bone fixation system
IL109929A (en) 1994-06-08 1998-04-05 Gotfried Yehiel Surgical instrument for use during connection of a fractured bone
US5320602A (en) 1993-05-14 1994-06-14 Wilson-Cook Medical, Inc. Peel-away endoscopic retrograde cholangio pancreatography catheter and a method for using the same
US5505735A (en) 1993-06-10 1996-04-09 Mitek Surgical Products, Inc. Surgical anchor and method for using the same
US5522844A (en) 1993-06-22 1996-06-04 Johnson; Lanny L. Suture anchor, suture anchor installation device and method for attaching a suture to a bone
US5370662A (en) 1993-06-23 1994-12-06 Kevin R. Stone Suture anchor assembly
US5462561A (en) 1993-08-05 1995-10-31 Voda; Jan K. Suture device
US5411522A (en) 1993-08-25 1995-05-02 Linvatec Corporation Unitary anchor for soft tissue fixation
WO1995005782A1 (en) 1993-08-27 1995-03-02 Robin Peter Brown Apparatus and method for surgically securing bone parts
US5762599A (en) 1994-05-02 1998-06-09 Influence Medical Technologies, Ltd. Magnetically-coupled implantable medical devices
US5512037A (en) 1994-05-12 1996-04-30 United States Surgical Corporation Percutaneous surgical retractor
US5642730A (en) 1994-06-17 1997-07-01 Trudell Medical Limited Catheter system for delivery of aerosolized medicine for use with pressurized propellant canister
US5460524A (en) 1994-06-24 1995-10-24 Anderson; Ross W. Device and method for saliva suction with tongue retractor and bit handle
US5464424A (en) 1994-06-27 1995-11-07 O'donnell, Jr.; Francis E. Laser adjustable suture
US5573540A (en) 1994-07-18 1996-11-12 Yoon; Inbae Apparatus and method for suturing an opening in anatomical tissue
DE69534233T2 (en) 1994-09-16 2005-10-27 Ethicon Endo-Surgery, Inc., Cincinnati DEVICES FOR DETERMINING AND MARKING TISSUE
JPH08196538A (en) 1994-09-26 1996-08-06 Ethicon Inc Tissue sticking apparatus for surgery with elastomer component and method of attaching mesh for surgery to said tissue
US5578032A (en) 1994-12-20 1996-11-26 Accurate Surgical & Scientific Instruments Corporation Bone clamp
US5626597A (en) 1995-02-21 1997-05-06 United States Surgical Corporation Percutaneous introducer
US5840078A (en) 1995-03-01 1998-11-24 Yerys; Paul Method and apparatus for mechanical attachment of soft tissue to bone tissue
AUPN205795A0 (en) 1995-03-30 1995-04-27 Palmisano, Richard George Apparatus and methods for treatment of obstructive sleep apnea and/or snoring
US6602248B1 (en) 1995-06-07 2003-08-05 Arthro Care Corp. Methods for repairing damaged intervertebral discs
FR2734147B1 (en) 1995-05-19 1997-10-10 Klein Jean Michel IMPLANTABLE OSTEOSYNTHESIS DEVICE
US7090672B2 (en) 1995-06-07 2006-08-15 Arthrocare Corporation Method for treating obstructive sleep disorder includes removing tissue from the base of tongue
US6132438A (en) 1995-06-07 2000-10-17 Ep Technologies, Inc. Devices for installing stasis reducing means in body tissue
US5662654A (en) 1995-06-14 1997-09-02 Incont, Inc. Bone anchor, insertion tool and surgical kit employing same
DE19532098A1 (en) 1995-08-30 1997-03-06 Stuemed Gmbh Device for endoscopic operations, in particular an expandable support epi-hypopharyngo-laryngoscope according to Feyh-Kastenbauer
US6805130B2 (en) 1995-11-22 2004-10-19 Arthrocare Corporation Methods for electrosurgical tendon vascularization
US5979456A (en) 1996-04-22 1999-11-09 Magovern; George J. Apparatus and method for reversibly reshaping a body part
US5893856A (en) 1996-06-12 1999-04-13 Mitek Surgical Products, Inc. Apparatus and method for binding a first layer of material to a second layer of material
US5718705A (en) 1996-07-16 1998-02-17 Sammarco; Giacomo J. Internal fixation plate
US5797919A (en) 1996-07-16 1998-08-25 Brinson; Keith Anthony Surgical bone clamp
DE29614901U1 (en) 1996-08-28 1996-10-31 Kramer Massow Klaus Surgical thread that has three functionally different sections made of different materials
EP0931258B1 (en) 1996-10-08 2002-09-11 Phenomenex, Inc. A direct screw-on cartridge holder with self-adjustable connection
US6668834B1 (en) 1996-11-01 2003-12-30 Bashir Zikria Anti-snoring apparatus
US6632224B2 (en) 1996-11-12 2003-10-14 Triage Medical, Inc. Bone fixation system
SE9604143D0 (en) 1996-11-13 1996-11-13 Pacesetter Ab Implantable electrode cable
US5954057A (en) 1997-02-12 1999-09-21 Li Medical Technologies, Inc. Soft tissue suspension clip, clip assembly, emplacement tool and method
AU6329598A (en) 1997-02-13 1998-09-08 Boston Scientific Ireland Limited, Barbados Head Office Stabilization sling for use in minimally invasive pelvic surgery
US5810824A (en) 1997-02-13 1998-09-22 Chan; Kwan-Ho Surgical fastener assembly and method for bone fracture fixation
US6039686A (en) 1997-03-18 2000-03-21 Kovac; S. Robert System and a method for the long term cure of recurrent urinary female incontinence
US5988171A (en) 1997-06-26 1999-11-23 Influence Medical Technologies, Ltd. Methods and devices for the treatment of airway obstruction, sleep apnea and snoring
US5868762A (en) 1997-09-25 1999-02-09 Sub-Q, Inc. Percutaneous hemostatic suturing device and method
AU1093099A (en) 1997-10-17 1999-05-10 Penn State Research Foundation; The Muscle stimulating device and method for diagnosing and treating a breathin g disorder
US6540695B1 (en) 1998-04-08 2003-04-01 Senorx, Inc. Biopsy anchor device with cutter
JP2002516696A (en) 1998-05-29 2002-06-11 バイ−パス・インク. Methods and devices for vascular surgery
US6997189B2 (en) 1998-06-05 2006-02-14 Broncus Technologies, Inc. Method for lung volume reduction
US6599311B1 (en) 1998-06-05 2003-07-29 Broncus Technologies, Inc. Method and assembly for lung volume reduction
US6161541A (en) 1998-06-09 2000-12-19 Influent Ltd. Hyoid expansion and suspension procedure
US7060021B1 (en) 1998-07-23 2006-06-13 Wilk Patent Development Corporation Method and device for improving cardiac function
US6240316B1 (en) 1998-08-14 2001-05-29 Advanced Bionics Corporation Implantable microstimulation system for treatment of sleep apnea
US6368326B1 (en) * 1998-09-28 2002-04-09 Daos Limited Internal cord fixation device
US6554833B2 (en) 1998-10-26 2003-04-29 Expanding Orthopedics, Inc. Expandable orthopedic device
DE60206274T2 (en) 1998-10-26 2006-06-08 Expanding Orthopedics Inc., Boston SPREADABLE DEVICE FOR ORTHOPEDICS
US6708060B1 (en) 1998-11-09 2004-03-16 Transpharma Ltd. Handheld apparatus and method for transdermal drug delivery and analyte extraction
US6611706B2 (en) 1998-11-09 2003-08-26 Transpharma Ltd. Monopolar and bipolar current application for transdermal drug delivery and analyte extraction
US6200330B1 (en) 1998-11-23 2001-03-13 Theodore V. Benderev Systems for securing sutures, grafts and soft tissue to bone and periosteum
EP2055244B1 (en) 1998-12-31 2012-02-01 Kensey Nash Corporation Tissue fastening devices
EP1187557A2 (en) 1999-01-08 2002-03-20 American Medical Systems International, Inc Surgical tack
US6104961A (en) * 1999-02-18 2000-08-15 Intermedics Inc. Endocardial defibrillation lead with looped cable conductor
US6315780B1 (en) 1999-04-12 2001-11-13 Accurate Surgical & Scientific Instruments Corporation Bone clamp for dynamic and non-dynamic compression of transverse fractures and method of use thereof
WO2000064378A1 (en) 1999-04-22 2000-11-02 Hugues Charles Device for anchoring a ligament on a bone structure
US7150680B2 (en) 1999-05-14 2006-12-19 Precimed S.A. Drive shaft coupling
US6423072B1 (en) 1999-05-19 2002-07-23 Stephen M. Zappala Bone anchor delivery device with an articulating head
US6482178B1 (en) 1999-05-21 2002-11-19 Cook Urological Incorporated Localization device with anchoring barbs
US6626899B2 (en) 1999-06-25 2003-09-30 Nidus Medical, Llc Apparatus and methods for treating tissue
US6183493B1 (en) 1999-08-24 2001-02-06 Pharmasys International, Llc Method and apparatus for the treatment of sleep apnea and related breathing disorders
US6431174B1 (en) 2000-08-10 2002-08-13 Pi Medical, Inc. Method and apparatus to treat conditions of the naso-pharyngeal area
US6450169B1 (en) 1999-09-17 2002-09-17 Pi Medical, Inc. Braided implant for snoring treatment
US6390096B1 (en) 1999-09-17 2002-05-21 Pi Medical, Inc. Needle with pre-loaded implant for snoring treatment
US6513531B2 (en) 1999-09-17 2003-02-04 Pi Medical, Inc. Proximal placement of snoring treatment implant
ATE331491T1 (en) 1999-09-17 2006-07-15 Restore Medical Inc IMPLANTS FOR ANTI-SNORING TREATMENT
US6523542B2 (en) 1999-09-17 2003-02-25 Pi Medical, Inc. Snoring treatment implant and method
US6502574B2 (en) 1999-09-17 2003-01-07 Pi Medical, Inc. Lateral stiffening snoring treatment
US6601584B2 (en) 1999-09-17 2003-08-05 Pi Medical, Inc. Contracting snoring treatment implant
US6516806B2 (en) 1999-09-17 2003-02-11 Pi Medical, Inc. Compliant snoring treatment implant
US6250307B1 (en) 1999-09-17 2001-06-26 Pi Medical, Inc. Snoring treatment
US6231561B1 (en) 1999-09-20 2001-05-15 Appriva Medical, Inc. Method and apparatus for closing a body lumen
US6636767B1 (en) 1999-09-29 2003-10-21 Restore Medical, Inc. Implanatable stimulation device for snoring treatment
US6783515B1 (en) 1999-09-30 2004-08-31 Arthrocare Corporation High pressure delivery system
US6408851B1 (en) 1999-10-01 2002-06-25 Manuel L. Karell Method and device for holding a tongue in a forward position
GB2357433A (en) 1999-12-22 2001-06-27 Estrange Peter L Intra-oral device
US6524317B1 (en) 1999-12-30 2003-02-25 Opus Medical, Inc. Method and apparatus for attaching connective tissues to bone using a knotless suture anchoring device
US6408852B2 (en) 2000-01-11 2002-06-25 Tnv Research And Development Oral orthesis to reduce snoring and sleep apnea symptoms
US6877513B2 (en) 2000-01-21 2005-04-12 Respironics, Inc. Intraoral apparatus for enhancing airway patency
US6296659B1 (en) 2000-02-29 2001-10-02 Opus Medical, Inc. Single-tailed suturing method and apparatus
US6312431B1 (en) 2000-04-24 2001-11-06 Wilson T. Asfora Vertebrae linking system
GB0013037D0 (en) 2000-05-31 2000-07-19 Atlantech Medical Devices Limi Tension measuring device
US6439238B1 (en) 2000-06-30 2002-08-27 Pi Medical, Inc. Snoring diagnostic and treatment
US6702739B2 (en) 2000-08-30 2004-03-09 Ricardo Levisman Holder
US6425900B1 (en) 2000-10-19 2002-07-30 Ethicon Endo-Surgery Method for attaching hernia mesh
US6447524B1 (en) 2000-10-19 2002-09-10 Ethicon Endo-Surgery, Inc. Fastener for hernia mesh fixation
US6527761B1 (en) 2000-10-27 2003-03-04 Pulmonx, Inc. Methods and devices for obstructing and aspirating lung tissue segments
US20020147382A1 (en) 2001-01-23 2002-10-10 Neisz Johann J. Surgical articles and methods
US7229453B2 (en) 2001-01-23 2007-06-12 Ams Research Corporation Pelvic floor implant system and method of assembly
US6602260B2 (en) 2001-02-02 2003-08-05 Ams Research Corporation Powered bone screw device
US6673023B2 (en) 2001-03-23 2004-01-06 Stryker Puerto Rico Limited Micro-invasive breast biopsy device
US20020138091A1 (en) 2001-03-23 2002-09-26 Devonrex, Inc. Micro-invasive nucleotomy device and method
US6748950B2 (en) 2001-04-30 2004-06-15 Closure Medical Corporation Compositions and medical procedure to treat snoring
US20020173803A1 (en) 2001-05-01 2002-11-21 Stephen Ainsworth Self-closing surgical clip for tissue
FR2824723B1 (en) 2001-05-15 2003-08-15 Univ Joseph Fourier MOUTHPIECE FOR A PHARYNX SENSITIVITY ASSESSMENT DEVICE, DEVICE COMPRISING SAME AND METHOD OF USE
US6685707B2 (en) 2001-09-25 2004-02-03 Walter Lorenz Surgical, Inc. Cranial clamp and method for fixating a bone plate
US6648921B2 (en) 2001-10-03 2003-11-18 Ams Research Corporation Implantable article
US7144363B2 (en) 2001-10-16 2006-12-05 Extensia Medical, Inc. Systems for heart treatment
US7201771B2 (en) 2001-12-27 2007-04-10 Arbor Surgical Technologies, Inc. Bioprosthetic heart valve
US7150750B2 (en) 2002-01-10 2006-12-19 Boston Scientific Scimed, Inc. Method and device for endoscopic suturing
US7017582B2 (en) 2002-02-04 2006-03-28 Restore Medical Inc. Stiffening pharyngeal wall treatment
US7146981B2 (en) 2002-02-04 2006-12-12 Restore Medical, Inc. Pharyngeal wall treatment
AU2003213688B2 (en) 2002-03-07 2008-10-02 Ams Research Corporation Transobturator surgical articles and methods
JP2003265621A (en) 2002-03-14 2003-09-24 Univ Nihon Indwelling and collecting type stent for disease in sleep apnea syndrome
US7191015B2 (en) 2002-04-11 2007-03-13 Medtronic Vascular, Inc. Devices and methods for transluminal or transthoracic interstitial electrode placement
US7131973B2 (en) 2002-05-16 2006-11-07 Boston Scientific Scimed, Inc. Bone anchor implantation device
US7146976B2 (en) 2002-08-06 2006-12-12 Mckown Joseph R Nasal cannula retainer
EP2272340B1 (en) 2002-08-19 2018-03-14 Ira Sanders Botulinum toxin
US7824693B2 (en) 2002-08-19 2010-11-02 Ira Sanders Treatment of fine wrinkles with clostridia neurotoxins
US7666435B2 (en) 2002-08-19 2010-02-23 Ira Sanders Treatment of fine wrinkles with clostridia neurotoxins
US8522790B2 (en) 2002-09-06 2013-09-03 Koninklijke Philips N.V. Stabilized magnetic force devices, systems and methods
US7721740B2 (en) 2002-09-06 2010-05-25 Koninklijke Philips Electronics N.V. Devices, systems, and methods using magnetic force systems in or on tissue
US8047206B2 (en) 2002-09-06 2011-11-01 Koninklijke Philips Electronics N.V. Magnetic devices, systems, and methods placed in or on a tongue
US7073505B2 (en) 2002-09-06 2006-07-11 Apneon, Inc. Systems and methods for moving and/or restraining tissue in the oral cavity
US20060289014A1 (en) 2002-09-06 2006-12-28 Apneon, Inc. Devices, systems, and methods using magnetic force systems in or on tissue in an airway
US7360542B2 (en) 2002-09-06 2008-04-22 Apneon, Inc. Devices, systems, and methods to fixate tissue within the regions of body, such as the pharyngeal conduit
US20070256693A1 (en) 2002-09-06 2007-11-08 Apneon, Inc. Devices, systems, and methods using magnetic force systems in or on soft palate tissue
US9463112B2 (en) 2002-09-06 2016-10-11 Koninklijke Philips N.V. Device, systems and methods having mobile ferromagnetic structures
US7845356B2 (en) 2002-09-06 2010-12-07 Koninklijke Philips Electronics N.V. Implantable devices, systems, and methods for maintaining desired orientations in targeted tissue regions
US8001971B2 (en) 2002-09-06 2011-08-23 Koninklijke Philips Electronics N.V. Devices, systems, and methods for stabilization or fixation of magnetic force devices used in or on a body
US7188627B2 (en) 2002-09-06 2007-03-13 Apneon, Inc. Magnetic force devices, systems, and methods for resisting tissue collapse within the pharyngeal conduit
US7216648B2 (en) 2002-09-06 2007-05-15 Apneon, Inc. Systems and methods for moving and/or restraining tissue in the upper respiratory system
US8528564B2 (en) 2002-09-06 2013-09-10 Koninklijke Philips N.V. Devices, systems and methods using magnetic force systems affecting both the tongue and the soft palate/uvula in the upper airway
US6955172B2 (en) 2002-09-06 2005-10-18 Apneon, Inc. Systems and methods for moving and/or restraining the tongue in the oral cavity
US8020560B2 (en) 2002-09-06 2011-09-20 Koninklijke Philips Electronics N.V. Devices, systems and methods using magnetic force systems affecting the tongue or hyoid muscles in the upper airway
US7441559B2 (en) 2002-09-06 2008-10-28 Koninklijke Philips Electronics N.V. Devices, systems, and methods to fixate tissue within the regions of body, such as the pharyngeal conduit
US8511315B2 (en) 2002-09-06 2013-08-20 Koninklijke Philips N.V. Devices, systems and methods using magnetic force systems in the upper airway
US8590537B2 (en) 2002-09-06 2013-11-26 Koninklijke Philips N.V. Devices, systems and methods using magnetic force systems in the tongue
US8807137B2 (en) 2002-09-06 2014-08-19 Koninklijke Philips N.V. Self-anchoring magnetic force implant devices, systems, and methods
US8707959B2 (en) 2002-09-06 2014-04-29 Koninklijke Philips N.V. Implantable devices, systems, and methods for maintaining desired orientations in targeted tissue regions
US20080066764A1 (en) 2002-09-06 2008-03-20 Apneon, Inc. Implantable devices, systems, and methods for maintaining desired orientations in targeted tissue regions
US8505539B2 (en) 2002-09-06 2013-08-13 Koninklijke Philips N.V. Devices, systems and methods using titrated magnetic force systems
US8074654B2 (en) 2002-09-06 2011-12-13 Koninklijke Philips Electronics N.V. Implantable devices, systems, and methods for maintaining desired orientations in targeted tissue regions
EP1545387A1 (en) 2002-10-04 2005-06-29 Stephen N. Brooks System and method for preventing closure of passageways
US7090690B2 (en) 2002-11-19 2006-08-15 Arthrocare Corporation Devices and methods for repairing soft tissue
US8562646B2 (en) 2002-12-19 2013-10-22 Boston Scientific Scimed, Inc. Anchoring to soft tissue
US7381222B2 (en) 2002-12-30 2008-06-03 Quiescence Medical, Inc. Stent for maintaining patency of a body region
US7992566B2 (en) 2002-12-30 2011-08-09 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US7160309B2 (en) 2002-12-31 2007-01-09 Laveille Kao Voss Systems for anchoring a medical device in a body lumen
US7481224B2 (en) 2003-01-22 2009-01-27 Koninklijke Philips Electronics N.V. Magnetic force device, systems, and methods for resisting tissue collapse within the pharyngeal conduit
ITGE20030007A1 (en) 2003-01-27 2004-07-28 Sergio Capurro COATED ELASTIC WIRE FOR SURGERY
US20040172084A1 (en) 2003-02-03 2004-09-02 Knudson Mark B. Method and apparatus for treatment of gastro-esophageal reflux disease (GERD)
US20060153876A1 (en) 2003-02-24 2006-07-13 Ira Sanders Cell membrane translocation of regulated snare inhibitors, compositions therefor, and methods for treatment of disease
US7328705B2 (en) 2003-03-10 2008-02-12 Mark Abramson Dental appliance for improving airflow through nasal-pharyngeal airway
US7198595B2 (en) 2003-03-26 2007-04-03 Pavad Medical, Inc. Cardiac apparatus including electroactive polymer actuators and methods of using the same
US7122043B2 (en) 2003-05-19 2006-10-17 Stout Medical Group, L.P. Tissue distention device and related methods for therapeutic intervention
US7311103B2 (en) 2003-07-29 2007-12-25 Checkmate Holding Company, Llc Method for treating obstructive sleep apnea syndrome
US7184842B2 (en) 2003-08-08 2007-02-27 Medtronic, Inc. Medical electrical lead anchoring
USD536792S1 (en) 2003-09-19 2007-02-13 Restore Medical, Inc. Implant delivery tool
US20050154412A1 (en) 2003-09-19 2005-07-14 Restore Medical, Inc. Airway implant and delivery tool
US7347812B2 (en) 2003-09-22 2008-03-25 Ams Research Corporation Prolapse repair
EP1722717B1 (en) * 2003-10-02 2013-06-19 Kevin A. Mansmann Hydrogels having charged surfaces for cartilage replacement
US7682374B2 (en) 2003-10-21 2010-03-23 Arthrocare Corporation Knotless suture lock and bone anchor implant method
US7237554B2 (en) 2003-10-31 2007-07-03 Restore Medical, Inc. Airway implant
US8821495B2 (en) 2003-12-15 2014-09-02 Koninklijke Philips N.V. System and method for hyoidplasty
US8080014B2 (en) 2004-12-15 2011-12-20 Koninklijke Philips Electronics N.V. System and method for hyoidplasty
US10524954B2 (en) 2004-02-26 2020-01-07 Linguaflex, Inc. Methods and devices for treating sleep apnea and snoring
US8025063B2 (en) 2004-03-10 2011-09-27 Apneos Corporation System and method for treatment of upper airway disorders
US7361168B2 (en) 2004-04-21 2008-04-22 Acclarent, Inc. Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
US7419497B2 (en) 2004-04-21 2008-09-02 Acclarent, Inc. Methods for treating ethmoid disease
US7462175B2 (en) 2004-04-21 2008-12-09 Acclarent, Inc. Devices, systems and methods for treating disorders of the ear, nose and throat
US7803150B2 (en) 2004-04-21 2010-09-28 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US7654997B2 (en) 2004-04-21 2010-02-02 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat
US20070167682A1 (en) 2004-04-21 2007-07-19 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US20060063973A1 (en) 2004-04-21 2006-03-23 Acclarent, Inc. Methods and apparatus for treating disorders of the ear, nose and throat
WO2005112788A2 (en) 2004-05-17 2005-12-01 Arthrocare Corporation Bone anchor
US20050274387A1 (en) 2004-06-10 2005-12-15 John Macken Method and apparatus for treatment of snoring and sleep apnea
AU2005254105B2 (en) 2004-06-14 2012-01-12 Boston Scientific Limited Systems, methods and devices relating to implantable supportive slings
US7186255B2 (en) 2004-08-12 2007-03-06 Atlas Spine, Inc. Polyaxial screw
US7887566B2 (en) * 2004-09-16 2011-02-15 Hynes Richard A Intervertebral support device with bias adjustment and related methods
US7836888B2 (en) 2004-09-21 2010-11-23 Pavad Medical, Incorporated Airway implant and methods of making and using
US7882842B2 (en) 2004-09-21 2011-02-08 Pavad Medical, Inc. Airway implant sensors and methods of making and using the same
US20070144535A1 (en) 2004-09-21 2007-06-28 Hegde Anant V Implant for treatment of sleep disorders
US7997266B2 (en) 2004-10-04 2011-08-16 Koninklijke Philips Electronics N.V. System and method for airway manipulation
US20060122634A1 (en) 2004-12-03 2006-06-08 Ino Takashi H Apparatus and method for delivering fasteners during valve replacement
FR2880253A1 (en) 2005-01-03 2006-07-07 Jean Francois Chantriaux Device for fixing flexible monofilament braided wire fragment in living organism on plate, comprises flexible part for supporting the material and rigid part intended to perforate the material
DE102005000702B4 (en) 2005-01-04 2007-08-23 Klinikum Der Universität Regensburg Device for central implantation in a tongue body
CA2635438C (en) 2005-01-10 2014-10-21 Guoping Yan Method and device for mandibular advancement
US8220466B2 (en) 2005-02-08 2012-07-17 Koninklijke Philips Electronics N.V. System and method for percutaneous palate remodeling
US8371307B2 (en) 2005-02-08 2013-02-12 Koninklijke Philips Electronics N.V. Methods and devices for the treatment of airway obstruction, sleep apnea and snoring
US7992567B2 (en) 2005-02-08 2011-08-09 Koninklijke Philips Electronics N.V. System and method for percutaneous glossoplasty
US8096303B2 (en) 2005-02-08 2012-01-17 Koninklijke Philips Electronics N.V Airway implants and methods and devices for insertion and retrieval
US9408742B2 (en) * 2005-02-08 2016-08-09 Koninklijke Philips N.V. Glossopexy adjustment system and method
US7322356B2 (en) 2005-02-24 2008-01-29 Restore Medical, Inc. Combination sleep apnea treatment
US20060195186A1 (en) 2005-02-28 2006-08-31 Drews Michael J Connectors for two piece heart valves and methods for implanting such heart valves
US7337781B2 (en) 2005-04-15 2008-03-04 Restore Medical, Inc. Implant for tongue
US7842042B2 (en) 2005-05-16 2010-11-30 Arthrocare Corporation Convergent tunnel guide apparatus and method
US7645286B2 (en) 2005-05-20 2010-01-12 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US20060271060A1 (en) 2005-05-26 2006-11-30 Arthrocare Corporation Threaded knotless suture anchoring device and method
US7644714B2 (en) 2005-05-27 2010-01-12 Apnex Medical, Inc. Devices and methods for treating sleep disorders
US7947076B2 (en) 2005-06-03 2011-05-24 Medtronic Xomed, Inc. Nasal valve treatment method and apparatus
US7238200B2 (en) 2005-06-03 2007-07-03 Arbor Surgical Technologies, Inc. Apparatus and methods for making leaflets and valve prostheses including such leaflets
EP1908516A4 (en) 2005-07-06 2010-09-01 Toyo Boseki Adsorbent and process for producing the same
EP1919397B1 (en) 2005-07-13 2013-01-02 Medtronic, Inc. Two-piece percutaneous prosthetic heart valves
US20070079833A1 (en) 2005-10-07 2007-04-12 Lamberg Steven B Intraoral mandibular advancement device for treatment of sleep disorders, including snoring, obstructive sleep apnea, and gastroesophageal reflux disease and method for delivering the same
US20070102010A1 (en) 2005-10-07 2007-05-10 Lemperle Stefan M Naso-pharyngeal tissue engineering
WO2007056583A1 (en) 2005-11-09 2007-05-18 Aspire Medical, Inc. Glossoplasty using tissue anchor glossopexy with volumetric tongue reduction
US20070144534A1 (en) 2005-11-30 2007-06-28 Carlos Mery System to prevent airway obstruction
US8214439B2 (en) 2005-12-06 2012-07-03 Microsoft Corporation Document object model API for MIME
EP1959864B1 (en) 2005-12-07 2018-03-07 Medtronic, Inc. Connection systems for two piece prosthetic heart valve assemblies
EP1797846A1 (en) 2005-12-13 2007-06-20 John A. Macken Method and apparatus for treatment of snoring and sleep apnea
US20070163603A1 (en) 2006-01-18 2007-07-19 Sikora Val J Tongue retention device and method of use
CA2642671A1 (en) 2006-02-16 2007-08-30 Pavad Medical, Inc. Self charging airway implants and methods of making and using the same
US7879034B2 (en) 2006-03-02 2011-02-01 Arthrocare Corporation Internally located return electrode electrosurgical apparatus, system and method
US8027718B2 (en) 2006-03-07 2011-09-27 Mayo Foundation For Medical Education And Research Regional anesthetic
EP1998719A1 (en) 2006-03-10 2008-12-10 Arbor Surgical Technologies, Inc. Valve introducers and methods for making and using them
US20070244529A1 (en) 2006-04-18 2007-10-18 Zoom Therapeutics, Inc. Apparatus and methods for treatment of nasal tissue
US7909038B2 (en) 2006-04-20 2011-03-22 Pavad Medical, Inc. Tongue stabilization device and methods of using the same
US9017361B2 (en) 2006-04-20 2015-04-28 Covidien Lp Occlusive implant and methods for hollow anatomical structure
US7909037B2 (en) 2006-04-20 2011-03-22 Pavad Medical Tethered airway implants and methods of using the same
JP5016667B2 (en) 2006-04-29 2012-09-05 メドトロニック,インコーポレイテッド Multi-membered prosthetic heart valve assembly, apparatus using the same, and method of using the same
AU2007249293C1 (en) 2006-05-12 2013-06-27 Arthrocare Corporation Middle turbinate medializer
US8190389B2 (en) 2006-05-17 2012-05-29 Acclarent, Inc. Adapter for attaching electromagnetic image guidance components to a medical device
EP2026701B1 (en) 2006-06-13 2016-05-11 Koninklijke Philips N.V. Glossopexy tension system
US8931486B2 (en) 2006-06-14 2015-01-13 Donald Lorne Halstrom Intra-oral appliance for treatment of sleep disorders
US7607439B2 (en) 2006-06-19 2009-10-27 Li Kasey K Tongue retention system
US7934506B2 (en) 2006-06-21 2011-05-03 Koninklijke Philips Electronics N.V. System and method for temporary tongue suspension
US8038712B2 (en) 2006-06-29 2011-10-18 Koninklijke Philips Electronics N.V. Methods and devices for rhinoplasty and treating internal valve stenosis
EP2037850A2 (en) 2006-07-06 2009-03-25 Quiescence Medical Inc Apparatus and methods for treating sleep apnea

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7213599B2 (en) * 2003-10-31 2007-05-08 Restore Medical, Inc. Airway implant

Also Published As

Publication number Publication date
US20120111341A1 (en) 2012-05-10
US8096303B2 (en) 2012-01-17
US20080066769A1 (en) 2008-03-20
US8757163B2 (en) 2014-06-24

Similar Documents

Publication Publication Date Title
US8757163B2 (en) Airway implants and methods and devices for insertion and retrieval
US8371307B2 (en) Methods and devices for the treatment of airway obstruction, sleep apnea and snoring
US11642123B2 (en) Systems and methods for tissue suspension and compression
JP5938434B2 (en) Implantable devices, systems, and methods for maintaining a desired orientation within a target tissue region.
US8915252B2 (en) Implant systems and methods for treating obstructive sleep apnea
US9393067B2 (en) Glassoplasty using tissue anchor glossopexy with volumetric tongue reduction
US8783258B2 (en) Implant systems and methods for treating obstructive sleep apnea
US8561617B2 (en) Implant systems and methods for treating obstructive sleep apnea
US8821495B2 (en) System and method for hyoidplasty
US20080058584A1 (en) Glossopexy tension system and method
US20110308529A1 (en) Systems and methods for treatment of sleep apnea
US20160022470A1 (en) Systems and methods for treatment of sleep apnea
JP5371971B2 (en) Implantable device, system and method for maintaining desired orientation in a target tissue region

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE